HEMIST&
RUM
HE NEWSWEEKLY
PHARMACY
I I I I I I I I I I I I I I I I I I
The UK's best-selling toothpaste*
...now with stripes!
1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
i i i i i
x
%
X
20 July 1996
I i I i I
3,000 pharmacies
may go if RPM lost
Malone go-ahead for
season ticket sales
Sex attack pharmacist
struck off Register
Update: performance-
enhancing drugs in sport
Keeping a
watching
brief on
eye care SK>
Pharmacists' biggest
fears are revealed
Sunderland TV star
Ortis looks for 'lurve'
Online at http://www.dotpharmacy.com/
-
When your customers
Household chemicals
Detergent hands
are itching to scratch,
d I X
I v
/ V
Plant allergy
Insect bites
you've no better way
( )
Eczema
Nickel allergy
to relieve them.
hydrocortisone
cream
WO -[ 5 HIVING ^
HC45 Hydrocortisone Cream quickly soothes itchy, inflamed,
irritated skin to provide the fast relief your customers need. In fact
there's no better recommendation you can make.
Trusted relief from everyday skin irritations
PRODUCT INFORMATION: Hc45 HYDROCORTISONE CREAM: Smooth white cream
containing HYDROCORTISONE ACETATE BP 1% w/w. Uses: For the relief of mild to moderate
eczema, irritant and allergic contact dermatitis and insect bite reactions. Dosage & Administration:
Apply sparingly to a small area, once or twice a day, for a maximum of seven days. Contra-indi cations,
Warnings etc: Hc45 should not be used on the eyes or face, the ano-gemtal area or on broken or
infected skin, including lmpeogo, cold sores, acne or athletes foot. The product should not be used
in pregnancy or in children under 10 years without medical advice. Packaging Quantity: Tube
containing 15g. RSP: £2.65. Legal Category: P. Product Licence Number: PL 0327/0039.
Product Licence Holder: Crookes Healthcare Ltd., Nottingham ^^^k CROOKES
NG2 3AA Date of Preparation: June 1996. ^^^F HEALTHCARE
c
COMMENT
ongratulations to the Community Pharmacy
Action Group lor its hard-hitting, albeit bleak
reading, report on the impact of abolishing
Resale Price Maintenance.
Although it confirms the worst fears of
pharmacists (see Business News, p96), it states
the pharmacy case effectively, while stressing the
pharmacy's importance in the community.
Of course, there may be those, both within and
without the profession, who see mass pharmacy
closure as for the common good. And it is also
disappointing to see other health professionals
backing Asda's stance, but it's hard to see how
there can be any long-term gain. The ultimate effect
of job losses, increased GP burden and dissatisfied
patients will be a hard one to bear for a
Government which introduced a Patient's Charter
and for GPs already burdened by overwor k.
It is patients to whom the Office of Fair Trading
must look when considering RPM's fate, so it is
good news that the Patients' Association has also
come out battling in the pharmacy comer (p78).
Guy Howland, the organisation's chief executive, is
a fervent pharmacy supporter. He believes the
profession's accessibility is key to its patient
popularity and stresses that that must be maintained.
He points out that the supermarkets who are trying
to change pharmacy aim to "make a fast buck, rather
than having anything to do with patients".
In contrast, he feels the local pharmacy could be
expanded to offer more services for patients to
supplement those on offer from the surgery.
His response is one of the positive spin-offs from
the whole RPM debate. Support such as this,
backed by the Deloitte & Touche (TAG report, will
have a long shelf-life and may be used in the future
to help pharmacy reach its potential - hopefully
with the RPM debate settled in the profession's
favour.
CHEMIST&
DRUGGIST
Editor Patrick < rrice,
MRPharmS
Assistant Editor Maria
Murray, MRPharmS
News Editor Marianne Mac Donald, MRPharmS
Technical Editor Fawz Faihan, MRPharmS
Beauty Editor Joanne Webb
Business Editor Guy L'Aimable, BA
Contributing Editor A< Incline de Mont, MRPharmS
Reporter ( lharles < lladwin MRPharmS
Art Editor Tony Lamb
Production Editor Vanessa Townsend, BA
Price List Colin Simpson (Controller)
I tarren Lai Kin, Maria Locke
Advertisement Manager .lull. in de lirnxelles
Assistant Advertisement Manager Doug Mytton
Display Advertisement Executives
Martin < lalder-Smith, Nick Fishet
Production Jenny I latl
Publisher Ron Salmon, FRPharmS
Publishing Director Roger Murphy
<0 Miller Freeman pic. [996
Chemist & Diuyiiisl mcorporatinij Retail
Ohwiir.l ^ I'Imiiii.ii v Hpij.ili:
Published Saturdays hy
Mi Her Freeman Professional I td
Sovereign Way, Timlnirlqe. Kent TN9 1RW
telephone 01732 364422
Telex 95132 Milt RE G
Fax: 01732 361534
E-Mail: tlieiiidrii() ,( ?ilnt|ih.imiacy com
Internet site
Imp //www ilnlpli.imi.il y i urn/
Subscriptions Home £115 per annum
Overseas & Eire t'ltj 1 . pel annum
including postage
£2 40 pei copy (postage extial
Circulation and subscription Royal
Sovereign House, Beresford Street
London SI I86BQ hi 0181 855 ////
Refunds on cancelled subscriptions will
only In' provided at the publisher's
discretion, unless specifically
guaranteed within the terms ot
subscription offer
The editorial photos used are courtesy
of the suppliers whose products they
feature.
\fl Miller Freeman
ABC
BUSINESS PRESS
CHEM&
DRUGGIST
VOLUME 247 No 6044 136th YEAR OF PUBLICATION ISSN 0009-3033
76
Report commissioned by the Community Pharmacy Action
Group spells out the clangers if Resale Price Maintenance is lost
Oxygen services to be devolved to local level 77
I )e] lartment of Health to devolve oxygen services by October 1
Pre-papent certificates to be sold through pharmacies 77
Regulations to be amended to allow sale directly to patients
From Practice to People 84
Show how yon work in practice and win a prize!
Update: the dope hope in sport
Drugs in sport, pharmacy needle exchange
schemes, plus Research Digest
Hill
care 90
Trends and changes in the eye care market
Counterpart assistant training 94
There is si ill time to register staff!
Nurse prescribing regarded as an opportunity by many 96
( Haxo survey reveals threats and opportunities for pharmacists
Co-op Health Care continues to expand 96
Five pharmacies acquired in North Midlands and North West
Dental relief aid deliver}' to Bihac in Bosnia
A pharmacist helps to deliver essential dental supplies
102
REGULARS
News
76
Cambridge Counterpart
94
Topical Reflections
73
Business News
96
Prescription Specialities
80
Classified Advertisements
97
Counterpoints
82
Business Link
98
Practice to People
84
About People
102
CHEMIST k DRI GGIST 20 JULY 1996
75
NEWS
000 pharmacies could go if RPM lost
Over 3,000 community pharma-
cies could face closure if Resale
Price Maintenance is lost, reveals
a report commissioned by the
Community Pharmacy Action
( rroup.
"Our concern," says CPAG
spokesperson and director of the
National Pharmaceutical Associ-
ation Tim Astill, "is that the
removal of RPM would force the
closure of many small pharma-
cies and reduce the services pro-
vided by others, resulting in a
threat to public healthcare."
The 'In defence of community
pharmacy' study by management
consultant Deloitte & Touche
shows that the public would
have access to fewer pharmacies
and would be forced to travel fur-
ther to get pharmaceutical
advice, with the 1 proportions of
vulnerable groups, such as the
elderly and those with young
families, higher in the areas most
at risk. There would also be a
reduced range of over the
counter medicines available and
job losses would be incurred.
The < >ftk e of F ur Tr riding last
investigated RPM in 1970 and is
to decide by the autumn if there
is any material change thai
would allow its demise. The
report divulges that there is
change, but it strengthens the
case for RPM retention, as phar-
macists are now more reliant on
branded medicines.
In 11)70, the average small
pharmacy derived 7 per cent of
turnover from medicine sales
and 10 per cent, from NHS dis-
pensing, with the margins on the
latter at around 26 per cent. Now
NHS dispensing accounts for 70
per cent of turnover, with mar-
gins down to 16 per cent, while
OTCs are responsible for 15-16
per cent of turnover, around 45
per cent of the profit.
The upshot of losing RPM
would be a saving of S180 mil-
lion, plus another in 00, 000 saved
in policing.
"Without RPM," says Mr Astill,
"there might be a short-term
gain, but there will certainly be a
long-term loss." And 91 per cent
of pharmacists surveyed by
<ilaxo Wellcome believe their
Numark is
tackling the
supermarkets
head-on with a
pharmacy advice
campaign. Terry
Morris, Numark's
managing
director, sees the
campaign as a
complement to the
Resale Price
Maintenance
defence: "Numark
totally supports
the retention of RPM and what we want from this campaign is for the
consumer to ask the question: when did a supermarket shelf last
advise me not to buy something?" Numark's 900 shareholder
pharmacies will highlight the advisory role of trained pharmacy staff
and compare that with what's on offer in an ordinary supermarket via
posters and shelf cards, which ask a series of advice-related
questions and issues the challenge: Try asking your supermarket shelf
these questions'
business viability will be threat-
ened (Business News, p96).
Supermarket chain Asda, at
the forefront of the fight to abol-
ish RPM, comments: "We are
well aware of the services that
community pharmacies deliver
The impact on healthcare of abolishing Resale Price Maintenance
• Up to 3,055 pharmacies
would be at risk of closure: one-
quarter of Britain's total.
• Up to 8.2 million people
whose pharmacy is at risk of clo-
sure could be affected.
• Additional travel costs of
between S4.4 million and SI 5.9m
would be incurred by people
affected by the closure of their
local pharmacy.
• If a tenth of those who treat
themselves with pharmacy-
bought medicines were to visit a
GP instead, the annual cost to
the NHS could be more than S4.7
billion.
# The range of non-prescrip-
tion medicines available would
be cut: the average pharmacy
carries 700 OTC lines, while
supermarkets cany 70.
• Between 800 and 3,000 jobs
could be lost if pharmacies close,
not including any pharmacists.
• The benefits of RPM would
be a saving of SI 80m if prices
were cut across the board (6p
per person per week ), but super-
markets are more likely to offer
seasonal reductions on adver-
tised products rather than
wholesale discounting.
• The cost of administering
RPM, around S100,000 annually,
would also be saved.
to the local community, but we
do not believe that RPM supports
local pharmacies."
Asda says that GPs and nurses
back its stance on RPM. In an
Asda mailing to 30,000 GPs, some
7,500 replies agreed that RPM
results in artificially high prices
for "common healthcare prod-
ucts". Only 40 replies disagreed.
But backing for RPM comes
from an even more powerful
source, the Patients' Associa-
tion. "With RPM loss there will be
a trade-off," says chief executive
Guy Howland. "Lowering prices
will undoubtedly cause some
exist ing pharmacies to close and
reduce choice. The public like
the access they currently get
from pharmacies and we need to
keep that available."
The OFT has been sent a copy
of the Deloitte & Touche report.
Pharmacists to be more clinical with methadone?
Pharmacy Group
MPs disappear from Westminster
for their three-month summer
break on July 20, with no sign of a
long-awaited Pharmacy Group
being established to promote the
interests of the sector.
Tory MP Sir Malcolm Thornton
and Labour's Alan Keen said last
year that they planned to set up a
group to lobby on behalf of phar-
macies and vowed to launch the
body early this year.
But Sir Malcolm admits he has
dropped out because of a lack of
time. "Unfortunately, I ran up
against the buffers," he says.
Mr Keen's office says the group
has yet to be set up, but insists
that the MP for Feltham still
intends it to go ahead.
Pharmacists' potential to adopt a
more clinical role in managing
methadone patients is to be
investigated by South Humber-
side's pharmacist-run Freelance
Needle Exchange.
Community pharmacist Dr
Rod Tucker, director of the Free-
lance Group and devisor of the
study, says: "The overall objec-
tive ( if the project is to determine
whether or not pharmacists can
play a greater role in the clinical
management of opiate-depen-
dent individuals."
South I lumber Health Author-
ity is paying SI per addict per day
for pharmacists to supervise the
methadone consumption of 30
patients over 13 weeks, plus an
additional S750 for evaluation. A
clinical audit, sheet will be main-
tained and clients will be
assessed using an opiate with-
drawal scale to titrate the
methadone dose. An initial three-
day assessment by the referral
agency scores various signs and
symptoms, such as sweating, agi-
tation and mydriasis, to establish
the degree of withdrawal. The
dose is titrated upwards until
symptoms are under control.
Thereafter, the pharmacist con-
tinues daily monitoring of the
patient using the same scale. A
change in the patient's drug-tak-
ing habit, such as taking addi-
tional opiates, can also be indi-
cated by changes in routine or
behaviour.
Every fortnight during the pro-
ject, the withdrawal scales are
scored and given to the prescrib-
ing agency responsible for the
overall management of the client.
From Practice to People -
deadline imminent
You've got less than two weeks
to enter the Glaxo Well-
come/C&D community phar-
macy award, From Practice to
People (see page 84).
The award will be granted to
three community pharmacists
who show how they are forging
links with other health profes-
sionals to benefit patients,
other primary care workers and
their business. Closing date for
entries is July 31, 1996, and win-
ning entries will be announced
on November 9.
Winners will be offered the
chance to attend one of the
major 1997 conferences or
choose from a range of manage-
ment courses.
76
CHEMIST & DRUGGIST 20 JULY 1996
NEWS
Oxygen to be devolved on October 1
The I 'epartmenl oi Health is to
devolve oxygen services i<> local
level by < ictobei 1
The Pharmaceutical Services
Negotiating Committee, winch
has opposed the move, will write
to local pharmaceutical commit-
tees with a model for local nego-
tiations as soon as it receives
mure detailed guidelines.
The NHS Executive expects
agreements wit h heall h auttv »ri-
ties in I"' made by January 1,
l!i!)7 ( 'ontractors should carry
on as before unlil they receive
further advice from then LP( 's.
The number of oxygen head sets
is to lir reduced, but contractors
who have to give up head sels
will be paid compensation.
PSN< ' warns dial monej is only
available f< a this financial year.
Remuneration The hull and
PSNC are poised on the brink of
a remuneration settlement foi
l!)!)ii/!i7. PSNC has been
pr< mused an i iffei I iefi »r< 1 the end
ol the month, aftei ii met with
health minister Gerald Malone.
This followed PSNC's rejection
oi the Moll's last offei of 3 per
cent in May (C&D May 25, p712).
PSNC chairman Wally Dove
says thai the offei w ill m it be put
to contractors. Providing an
agreement is reached then
PSNC will discuss the distribu-
tion of the global sum at its Sep-
tember meeting and the new
si ruct ure sin mill be in ] ilace by
t ictobei 1
Director The first advertise-
ment for the new position of
duei lor w ill be placed Ihls week
iii the PSNC News and pharma-
ceutical piess
MPs The PSNC wants to thank
tin isc pharmacists who wr< ite to
their MPs to raise awareness of
pharmacy remuneration It also
wants io encourage LP( 's to con-
tinue inviting MPs to \ isii phar-
macies, so thai they gel a bettei
understanding ol community
phai ma< V issues
Control of Entry Most of the
comments made by PSNC over
the draft guide concei ning ( 'on-
trol ol Entry regulations have
been acce] ited I iy the DoH and
will be inc< »rj » >rate< I into the sec-
ond draft.
Taxation advice Advice will be
senl to LP< 's setting oul the lax
implications for allow ances paid
foi members attending LPC
meetings.
Primary care The I lull has indi-
i ated that the NHS Executive
would welcome further position
papeis from PSN( ■ on the health
minister's paper 'Primary care:
the future'. PSNC will place
emphasis on the need for non-
global sum money to be made
available for local initiatives.
Pilot trials PSNC has been in
discussion with the DoH over
pilot trials in 1996/97. Il is stress-
in;; thai pharmacists should
receive then share of any money
saved m icpeai dispensing
pilots.
GP co-operatives PSN( is con
cerned that there has been no
national approach by local med-
ical councils to the pharmacy
pi c pfessii m ovei the setting up i >l
GP co-operatives to provide
emergency oul of hours medical
services. PSNC secretary Steph-
en Axon is against health author-
ities extending existing phar-
macy rota hours to beyond those
of surgeries
NAIIAT PSNC wants to create a
dialogue with the National Asso-
ciation of Health Authorities and
Trusts over developing pharma-
ceutical services. It is hoped that
money other than the global sum
will be made available fi ir such
services.
Conference The third confer-
ence organised jointly with the
Royal Pharmaceutical Society
and the Pharmaceutical Advisers
( JrOlip W ill be held al the Mello-
pole Hotel, Birmingham, on
Novembei 7. The theme will be
'Pharmacists as partners in
healthcare'.
LPC Conference PSNC has
received comments from
LPCs about the March confer-
ence. The Committee will be
looking at making the working
group sessions more interactive,
ami will be targeting MPs more
lor the dinner.
New research suggests that hairy men are more intelligent. More details can be found on p80
Sale of season tickets receives go-ahead
Pharmacists are to be allowed to
officially sell prescription pie
payment certificates. The health
minister, Gerald Malone, an-
nounced in a written answer lasl
week that the Gi ivei iinient "pro
poses to amend cm rent regula-
tions later this yeai to allow com-
munity pharmacists who wish to
do so lo sell prescription pie
payment certificates directly to
patients".
Al present, patients must
apply directly to then health
authority, but m some areas
pharmacists have been supply-
ing certificates with the tacit
approval of the 1 IA
"We have been making repre
sentations lor some time foi a
change in the regulations," says
Pharmaceutical Services Negoti-
ating Committee assistant secre-
tary Mike Kins*. "Now we will he
discussing details with the Nils
Execul ive."
A Department of Health spokes-
man says Ihe changes should be
made bcli n e next April and discus-
sions a i e in progress with relevant
bodies. One of the DoH's main con-
cerns is Ihe security ol the certifi-
cates held in pharmacies
The National Asthma Cam
paign has been lobbying lor a
greatei awareness of 'season
tickets', which Mr Malone says
will be further publicised after
I he n 'gulat ions are changed.
certification and reward
Medicines counter assistants
are m iw completing ( 'hem ist &
Dnifjgist's ( 'am bridge < ounler-
part course and certification is
under way.
The College of Pharmacy
Practice hopes to have its cer-
tificates of accreditation
printed by Ihe end of July. < '&D
will then begin a search of its
computer records to find out
which assistants have success-
fully passed all modules in the
previous lour weeks; their
pharmacist will then get a letter
lo sign and rel urn confirming
joint c ompletion ol' all case
studies and that each assis-
tant's customer communica-
tion skills are satisfactory.
Within one month of receipt of
that letter from ihe pharmacist
the assistant should receive a
CPP certificate of accredita-
tion.
Each month, ( \Ki> will give
bottles ol' champagne lo a suc-
cessfully-accredited assistant
and their pharmacist - one PIN
will be draw n from a batch ol'
accreditees.
Al Ihe end of this year, one
accredited assistant will win a
weekend holiday lor two by
prize draw, courtesy ol' White-
hall Laboratories,
• Registration form and fur-
ther information on page 9 1.
CHEMIST H. DKI GGIST 20 JULY 1996
n
s
Pharmac ists should be given an
expanded role in the primary
care arena, according to the
Patients' Association.
Guy Howland, PA chief execu-
tive, says the Association is in the
process of writing a paper on the
future of pharmacy, which will
place pharmacists at the fore-
front of primary care. "Our whole
thrust is that we want to see a
role switch from dispensing to
A veteran pharmacist who
bought more than £11,000 of
drugs from the hack of an un-
licensed wholesaler's car was
or dered to be struck off the Reg-
ister this week.
John Aloysius Judge, 56, super-
intendent pharmacist at Snow-
drop Pharmacy, Canterbury,
admitted purchasing unlicensed
drugs, but claimed he had been
unaware that I hey were unli-
censed at the time.
His supplier - Pierre Schaffer
of Palm Bay, Margate - has
already been responsible for the
striking off of 1 1 other pharma-
cists, with four more yet to
appear before the Statutory
Committee ol Ihe Royal Pharma
ceutical Society.
Society inspectors visited Mr
Judge's pharmacy in October,
1993, where they discovered 22
A pharmacist who terrorised a
young woman by breaking into
her flat and asking for sex was
struck off the Register by a disci-
plinary panel this week.
Rajinder Singh Atwal, 25, who
was studying at Manchester Infir-
mary at the time, was jailed for
four years by Manchester Crown
Court in May last year, after
being convicted of burglary with
intent to commit rape. He gradu-
ated from John Moore University
in Liverpool just a year before
forcing his way into the 25-year-
old woman's flat and threatening
to sin >ot her if she didn't have sex
with him.
The Statutory Committee of the
Royal Pharmaceutical Society was
told Mr Atwal had been out drink-
ing on the night of the offence, cel-
ebrating the successful presenta-
tion of a paper on ast hma and a job
offer with Lloyds Chemists.
undertaking consultations, ad-
vising, prescribing and supple-
menting the work of the doctor
and nurse," says Mr Howland.
He believes that pharmacists'
skills can be put to better use. "If
we do not utilise the skills in pri-
mary care more effectively, then
primary care as we know it will
not survive. Let's get pharmacists
to solve the primary care crisis."
He feels that there should be a
consignments of products from
Mr Schaffer, worth SI 1,301.
Josselyn Hill, solicitor to the
Society, told the hearing that Mr
Judge, who had been practising
for 32 years, bought medicine
from the back of Mr Schaffer's
car and received handwritten
invoices, although not all of the
products were unlicensed.
Mr Judge of Petham, Canter-
bury, who admitted misconduct,
said he had trusted Mr Schaffer
and assumed his supplies were
"authentic".
Mr Judge said he had been told
by Mr Schaffer that he would be
supplied at "much keener" prices
because he had taken care of Mr
Schaffer when he suffered a dia-
betes attack in the pharmacy.
In a letter to the Society, Mr
Judge, who sold the pharmacy in
February this year but continued
Detective sergeant Steve Mc-
Gahey told the hearing the victim
had gone to bed at 1.45am on the
night of June 24, 1994. At around
3.30am, Mr Atwal approached
the entrance to the block and
began talking to two residents
who believed he knew somebody
and let him in. "He forced the
front door of her flat and went to
her bedroom. She awoke and
saw him standing close to her
bed."
Mr McGahey said the victim -
who did not know Mr Atwal -
asked him how he got inside her
home. He showed her a bunch of
keys and claimed he had believed
a girl called Leigh lived there.
"He then asked her if she
would consent to making love
with him and said she would
have no choice in the matter
because he would shoot her. She
was absolutely terrified and
re-think on training so that all
health professionals share a core
base, and pharmacists will be
allowed to develop their diagnos-
tic and prescribing skills.
The report is expected in Octo-
ber, but the PA is keen to collate
pharmacist evidence on how
progress can be made. Informa-
tion should be sent to: The
Patients' Association, 8 Guilford
Street, London WC1N IDT
to work as a locum, said: "With
the benefit of hindsight, I accept
my actions were at best naive
and at worst stupid."
In mitigation, David Reissmer
told the Committee that Mr
Schaffer was a trickster who had
possibly put on his "hypoglae-
cemic attack" to gain Mr Judge's
sympathy and confidence.
"It was not more than ig-
norance in that he did not know-
some of the drugs were un-
licensed, although he accepts
today that he should have done."
(fiving the Committee's deci-
sion, chairman Gary Flather QC
said Mr Judge is one of the
longest-serving pharmacists to
have been caught out in the
'Schaffer affair'. He told Mr
Judge that the Committee would
not entertain any application for
restoration for nine months.
started shouting 'rape' loudly."
Mr Atwal then panicked and
ran from the flat. However, he
was unable to find the way out
and he smashed a window.
Bleeding profusely, he then
banged on another resident's
door claiming he had been
mugged. He was taken to hospi-
tal but was later arrested after
the woman called the police.
Mr Atwal, who is now serving
his prison sentence, broke down
in tears as he told the Committee
he could make no excuse for his
behaviour. He said he committed
the offence "in a drunken haze".
Committee chairman Gary
Flather QC said the Committee
had no option but to strike him
off because of the conviction but
added that the Society would
entertain an application for
restoration in 1998 - he is due for
release in Dec ember next year.
WCPPE goes on-line
The Welsh Centre for Post-gradu-
ate Pharmaceutical Education
can now be accessed on the
Internet.
Aimed mainly at pharmacists I
living in Wales, the site offers an
index of literature for community
pharmacists, a calendar of Welsh I
pharmacy events and articles
published or presented by the
WCPPE's staff.
This will soon be expanded to
offer a distance learning pack
ordering system or allow reserva-
tion at a WCPPE evening course,
with plans to put computer- I
assisted learning material onto H
the Net . The WCPPE's home page
address is http://www.cf.ac.uk/
uwcc/phrmy/WCPPE/pindex.
html. Its e-mail address is at: I
WelshCPPE@cardiff.ac.uk.
• Boots has also set up an Inter-
net site (Website address: www. I
Boots.c-o.uk.) offering advice on
common ailments, pharmacy ser-
vices and a vitamin database.
More Sun E45
recalls for Crookes
Hot on the heels of last month's
recall of seven batches of Sun I
E45 Sun Block Cream, Crookes
Healthcare is now recalling all
remaining stock of Sun E45 Fac-
tors 8 and 15.
Stock should be returned to
wholesalers or Crookes' territory
managers. Full refunds will be
given, with replacement stock
available from July 29. Pharma-
cists with any queries should tele- I
phone 0115 968 8711.
MCA cuts waiting
time for assessment
The Medicines Control Agency is
maintaining its status as the
fastest authority in the world for I
1 1 ii ■ assessment i 'I new di ngs
The MCA's sixth annual report I
and accounts for 1995/96 shows I
that the Agency has cut the mean H
assessment time to 51 days for
applications containing new ac-
tive substances. Application fees
have also been reduced by
4 per cent.
Slimming pills stay
The Department of Health has
rejected calls for a ban on slim-
ming pills, such as dexenflu-
ramine, fenfluramine and maxin-
dol, arguing that the drugs can be
useful in the treatment of obe-
sity. However, health minister
Gerald Malone has asked for
tighter prescribing guidelines.
Schaffer affair rolls on and on
Striking off follows sex attack
m
CHEMIST & DRUGGIST 20 JULY 1996
Over 80 per cent of
elderly on repeats
( Iver so per cciii of eldei ly patients
are on repeal prescriptions, bui a
quarter are inconvenienced by hav-
ing in make a return trip in the
pharmacy because of 'owings'.
According to a survey by Help
the Aged, the mosl popular service
Offered by pharmacies is home
delivery, used by lo pei cenl of the
over-70s. Around a third of those
surveyed in England and Wales said
they were nol completely satisfied
with their current means of receiv-
ing repeals
"The efforl of visiting GPs and
having to keep visiting pharma-
cies adds up In a .ureal deal of
time an inconvenience," says
Help the Aged's head of public
affairs, Mervyn Kohler.
The report also reveals thai
71 per cenl of people o\el 60
suller from ai leasl one long-
standing illness. half 1 1 (nil
rheumatism oi arthritis, a third
from hypertension, and respira-
tory illness or heart disease
afflicts one-quat ter.
SHS hits the road
If you feel ignorant about coeliac
disease or have patients who
would like lo know more, then
Scientific Hospital Supplies has
the answer.
In a series of SHS autumn sem-
inars, aimed specifically at phar-
macists and their customers, a
gastro-enterologist will reveal
the latest advances in research,
w hile a Iu\ ela home ec( inoiuisl
will demonstrate gluten-free
recipes
The seminar dales are Septem
ber 5 (Dundee), ( ictober 18 (Nor-
wich) and Novembei 28 (South-
aiuplon ) Kurt her inloi mat i< m is
available from the Juvela adv ice
line on 0151 228 1992.
( loeliac disease affects one per-
son m every 2,500 in the UK.
CPPE workshop on
patient counselling
The ari of patient counselling
collies under the microscope in
the ('cnirc foi Pharmacy Post-
graduate Education's autumn
W ' irkshl )| i series
The counselling skills series
will run from September lo
December, with the help of local
( TITO i utors and presental i< >ns I >y
qualified counsellors
Topics lo be explored iik hide
the need for counselling and the
additional skills required,
The ( !PPE's workshop pro
gramme in spring will locus on
medicines management, which
will he selected on a local basis.
A fair day's
pay ,„ but
only for some
I make no apology for quoting
from the front page of the
Guardian (Thursday, July 11):
"There can be very few people
here or anywhere else who
have sacrificed more in pay
restraint than members of this
House," Alf Morris, Labour. I
beg to differ. In case Mr Morris
is unaware of pharmacy's
current problems, there is one
profession which has not only
sacrificed but has been
sacrificed on the altar of
Treasury frugality.
Community pharmacy is
rapidly approaching a crisis of
recruitment that is purely a
function of the dissatisfaction
of pharmacists at the salaries
currently being offered. Our
pay is an insult to any
profession and would be
laughable if it was not so
serious. Job seekers are
voting with their feet and
employers are now resorting
to overseas recruitment in
order to fill the gap left by our
own graduates who are
seeking employment
elsewhere.
I do not expect that the
Department of Health will pay
any more attention to the
current situation than it has to
reasoned argument in the
past. However, before the
service is starved of the vital
new blood it needs to develop
its own 'New Age', perhaps
Mr Morris and his like-minded
parliamentarians should be
reminded of pharmacy's
parallels. Having enjoyed the
luxury of voting for their own
fair pay rise, might they now
pressurise the DoH into
similarly granting community
pharmacy's reasonable
demands?
Playing piggy
in the middle
The saga of melatonin has
moved on since I last made
light of a situation that could
now find retailers as piggy in
the middle of a serious
confrontation between the
Medicines Control Agency and
healthfood manufacturers.
The MCA considers that
melatonin is a hormone which
_._cal.
Reflection
has a physiological function
and is therefore "medicinal in
function". On this basis, it has
classified it as a medicine and
has warned manufacturers
and retailers alike that it
should not be sold until a
product licence is granted.
However, some manufacturers
- and Pharma Notd in
particular - dispute this
classification and claim that,
since melatonin is naturally
present in many fresh foods, it
is a food supplement.
Who is right in law may
eventually have to be decided
by the courts. What is clear is
that many products,
melatonin included, are
presently marketed under the
guise of 'food supplements'
when their use is obviously
medicinal.
Wild third party curative
claims are made, often in the
pages of the popular press, for
products which rarely live up
to the expectations of their
desperate purchasers.
However, they do achieve a
very lucrative return for their
producers without the
inconvenience of having to go
through the process of
obtaining a product licence!
I hope that this court case
may clarify the medicinal
status of 'food supplements',
but even if it is non-definitive,
the resulting publicity may
attract sufficient political will
to tackle a real legislative
problem that at the moment
allows the mavericks of a
mainly responsible industry to
exploit the gullibility of a lay
public desperate for that
'miracle cure'.
A change
for the better
at Glaxo?
Glaxo's agency scheme was
introduced in order to bring
this giant of the
pharmaceutical industry
closer to its customers. The
result, for me at least, has
been a complete disaster, with
poorer discounts, more
paperwork and non-existent
presentation. Every purchase
of a Glaxo product costs me
money, so I just hope that the
rumour of a change in the
agency scheme is true (C&D
July 13, p62).
So far, Glaxo has
disdainfully ignored all pleas
for fair play and has continued
to actively discriminate
against the small
independents. If you are a
multiple chain of pharmacies,
many goodies will flow out of
Brentford, but, for me, the
company remains an
expensive luxury for whom it
is more important to persuade
local medical practices to
adopt new asthma delivery
systems than it is to service
the local pharmacy.
I would prefer that the
agency scheme was scrapped
altogether, but the rumoured
change is far more likely. If
that is true, then perhaps this
time my welfare will be
protected by Glaxo - and not
penalised!
CHEMIST & DRUGGIST 20 JULY 1996
79
IPTsnecials
■■■■HI
Salmeterol receives
IOC approval
Serevent (salmeterol) has be-
come the first long-acting bron-
chodilator to be approved by the
International Olympic Commit-
tee, a decision that will be wel-
comed by asthmatic athletes
c ompeting in this year's games in
Atlanta.
The drug was approved follow-
ing evidence that it did nol
enhance sporting performance. It
is expected to benefit athletes on
short-acting bronchodilators who
do not want the risk of break-
through symptoms and conse-
quent compromised performance.
The use of the drug is permitt-
ed by inhaler only and the ath-
letes must declare that they
intend to take it by writing to the
relevant medical authority prior
to competition.
Bayer launches new
versatile lancets
Bayer has launched a new type of
lancet designed to fit any finger-
pricking device for which lancets
are prescribable.
Baylet lancets (200-pack, basic
NHS price S6.08), which are 25
gauge for pain-free penetration,
can now be dispensed against any
prescription for blood glucose
monitoring lancets.
The new lancets solve the prob-
lem for the phar macist of trying
to match the appropriate product
with the finger-pricking device
the patient is using.
Bayer Diagnostics UK Ltd. Tel:
01256 29181.
Sporanox now available
as an oral solution
Sporanox is now available as an
oral solution containing lOmg
per ml of itraconazole.
The liquid has improved ab-
sorption and enhanced bioavail-
ability compared to the capsules
and is indicated for oral and/or
oesophageal candidosis in HIV
positive and other immunocom-
promised patients. The dose is
200mg ( 20ml) daily to be taken as
a single dose or divided into two
doses for one week. Treatment
should be continued for another
week if there is no initial
response.
For resistant cases, 200-400mg
should be given daily in one or
two intakes for two weeks. If
there is no response after that
period, treatment should be
extended for another two weeks.
Sporanox liquid is recom-
mended to be taken without food
for maximum absorption. The
liquid should be swished around
the mouth before swallowing.
The mouth must not be rinsed
after swallowing.
Sporanox liquid (NHS price
£52.28) comes in 150ml bottles
and is accompanied by a measur-
ing cup.
Janssen-Cilag has also launch-
ed 60-capsule packs of Sporanox
lOOmg (in addition to existing
packs of four and 15) for patients
needing long-term maintenance
therapy, such as those with AIDS
or prolonged neutropenia. The
NHS price of the new packs is
£89.84
Janssen-Cilag Ltd. Tel: 01494
567567.
Videx given first-line indication for HIV
Videx (didanosine, DDI) has
received approval for use as a
first-line adjuvant therapy in HIV
infection.
The close is 125mg eveiy 12
hours for an adult under (iOkg
and 200mg eveiy 12 hours for
adults of 60kg and over.
The approval was reached
through a mutual recognition
procedure across 15 European
countries and is now awaiting
the final seal from the Medicines
Control Agency, which is ex-
pected in the next few weeks.
Bristol-Myers Squibb is cur-
rently evaluating once daily
administration of Videx and new
formulations.
Preliminary results of a US
study presented at last week's
international conference on
AIDS in Vancouver found that
combination therapy of didano-
sine and stavudine (D4T) may
have potent antiviral effects and
that suppression of viral load is
sustained for at least one year.
The combination was also found
to be well tolerated.
Bristol-Myers Squibb. Tel: 0181
572 7422.
Seroxat (paroxetine) has been
granted a licence for use in the
prevention of relapse of panic
disorder. The standard dose
(40mg daily) for panic attacks
should be used. Paroxetine is the
only antidepressant in the UK to
be licensed for both treatment
and prevention of relapse of the
disorder.
SmithKline Beecham
Pharmaceuticals. Tel: 01707
325111.
Glamin infusion solution
Pharmacia & Upjohn has
launched Glamin, an amino acid
infusion solution containing
supplemental glutamine. It is
available in 500ml bottles at an
NHS basic price of £26.38.
Pharmacia & Upjohn Ltd. Tel:
01908 661101.
Wellcome interest
Zovirax Cream 2g tube (POM) is
now being distributed by Glaxo
Wellcome UK, but the OTC packs
of the tube and the pump will
continue to be available from
Warner-Lambert Consumer
Healthcare. Dermal cream 30g, on
the other hand, will no longer be
distributed by Warner-Lambert
but by Glaxo Wellcome only.
Glaxo Wellcome UK Ltd. Tel:
01270 508030.
Kefadini singles
All Kefadim (ceftazidime) vials
are now supplied in single units.
The new NHS basic prices are
500mg/10ml, £4.95; 1g/20ml, £9.90,
2g/50ml and 2g/100ml, £19.80.
Eli Lilly & Co Ltd. Tel: 01256
315000.
MEDICAL MATTERS
ooster for MMR introduced
From October, all pre-school
children will be offered a booster
dose of the measles, mumps and
rubella (MMR) vaccine.
The second dose will be avail-
able to children just before they
start, school, alongside boosters
of the diphtheria, tetanus and
polio vaccines. It is expected to
increase the protection of the
first MMR given at 12-15 months
and prevent the build-up of a
large number of children suscep-
tible to measles.
To ensure no child is over-
looked, the Department of
Health is also organising a catch-
up programme. This means that
all children who were too young
to be immunised in the 1994
measles/rubella campaign, but
who have already had their pre-
school boosters by the time the
MMR second close conies in, will
be offered it.
The catch-up programme will
usually be run by general practi-
tioners and call-up of children
will be by health authority/Trust
Child Health System computer
unless it is initiated by the GPs
themselves.
The DoH will be supporting the
new campaign with publicity
material for the public and
healthcare professionals.
Hairy chest - a sign of intelligence?
Hairy men should bare all and be
proud. After all, it is a sign of
intelligence, according to a study
presented at last week's Con-
gress of the Association of Euro-
pean Psychiatrists in London.
The study, conducted by Dr
Aikarakudy Alias, of the Chester
Mental Health Centre in Illinois,
found a link between body hair,
intelligence and academic ach-
ievement in men.
He found that 45 per cent of
medical students in America
were 'very hairy' compared to
less than 10 per cent among the
general male population. In
India, medical students and engi-
neering students were found to
have more body hair than manual
labourers and to achieve better
results in their degrees than
'smoother' colleagues.
Menil.eisol MENSA also had a
tendency to thick body hair,
while some of the most intelli-
gent men appeared to have haiiy
backs as well as chests.
Dihydrotestosterone, a variant
of testosterone that is associated
with male sexual characteristics
and mental faculties, is thought
to be responsible for the link.
However, one famous excep-
tion is Albert Einstein, who had
no body hair at all.
80
CHEMIST & DRUGGIST 20 JULY 1996
THERE'S NO MORE
EFFECTIVE COMBINATION THAN
MYCIL AND CLOTRIMAZOLE.
Mycil Gold Clotrimazole contains 1%
clotrimazole, one of the most effective athletes
foot treatments available.
And with your customers' confidence in
the Mycil brand name, your recommendation
will be reassuring as well as effective.
So next time you're looking tor a
treatment that's effective in more ways than one,
remember Mycil Gold.
It'll soon show athlete's toot a clean
p. nr of heels.
• i
HHHj^HHHHjjSMUaHHfl Clotrimazole 1 %
There's no better recommendation
for persistent athlete's foot
Product Information: Mycil Gold Clotrimazole
Topical antifungal cream containing l% clol azoic, Use: Broad-spectrum antifungal cream
I" 1 the treatment ol athlete's foot and other fungal infei tions mm h .is dhobic h. h, intertrigo,
fungal nappy rash and ringworm. Contra-indications: hypersensitivity to any ol the
ingredients Precautions: I lo no! use in or near eyes Not recommended foi use in
pregnancy and lactation Dosage: Apply to the affected area think and evenly 2-3 times daily
Side-effects: Karely, mild transient burning or irritation after applying the cream
Packaging quantities: 20g tube. P (in box) RSP: £2.99. PL: 10622/000-1 Licence
Holder: Dominion Pharm.i lid Haslemere, Surrey GU27 l|l ^fl^CROOKES
Manufactured by: I ileh.im I le.ilth. .in I id Alton Hants CiU.W XJR ^ftU0f H 15 A I ,T1 1( 'A K K
COUNTERDoints
with Forehead-C
Foreheatl-C is a new
forehead-sized cooling
sheet, said to soothe
headaches and relieve
fever in babies and young
children. The active
ingredient is super-
hydrated aloe vera which
has a cooling effect when
placed on the forehead. A
packet of three sheets
retails at £1.99.
According to Lina
Trading, advantages of
the products are that it is
easy to apply, it provides
instant comfort; aloe vera
is good for the skin; and
the sheet contains very
little menthol (its vapours
can irritate the eyes).
Lina Trading is
supporting the launch
with a £60,000 television
advertising campaign
within London and the
Home Counties area for a
one-month period during
September/October.
The television
advertisement will
feature a Freefone
number which viewers
can use to obtain
information about the
nearest stockist.
Mothercare will be
stocking the product
during the campaign and
Lina is currently
recruiting pharmacies
within the area to do
likewise.
Lina Trading Ltd. Tel: 0171
629 4144.
Complete ad
knocks juggling
'Are you still juggling
with a multi-bottle
system?' is the catchline
for Allergan Complete's
£250,000 national
consumer campaign.
The month-long
campaign includes full-
page, colour
advertisements in
national newspaper
magazines, including the
Mail on Sunday's
Night and Day,
the Sunday Times
magazine, and the
Independent
magazine. The
Even in y Sta ndard 's
ES magazine is also
being included to give
extra emphasis in the
London area.
Allergan group
Colgate's added value Plax packs
Colgate-Palm< ilive
is running an
added value
consumer offer on
Colgate Plax
mouthrinse.
An eye-catching
neck collar on
500ml slock will
carry a money-off
coupon towards
the purchase of a
Colgate Total
toothbrush,
prompting consumers to
stock up across the
Colgate range, and at the
same time encouraging
them to change their
toothbrush regularly. The
offer runs for two months
and returns on the 250ml
bottles from mid-
September for a further
two months.
The collar also features
the 'Plax Worx' message
from the high-profile
poster campaign, which
will be back for a second
burst during August. The
campaign is part of a S 1
million spend behind
Colgate Plax this year.
Colgate-Palmolive Ltd.
Tel: 01 483 302222.
Blisteze and Blistex give lips the kiss of life
I >cniln Hi is suppi ii ling its
cold sore brands -
Blisteze and Blistex -
with a national
promotional campaign
starting in September.
Nearly ,S2 million is
being invested in the
campaign, which is set to
run dining the winter
months and feature on
cinema screens, in the
press and at point of
sale.
The campaign for
Blisteze targets 15-24-
year-< >lds with its
'Blisteze - it's the cream'
cinema commercial. The
30-second advert will be
seen on 1,,S()I) cinema
screens from October to
March next year, hitting
over 50 per cent of the
target audience.
Advert ising with a
similar theme will appear
in teen magazines from
September, backed by
POS shelf wobblers.
Similar campaign
support for Blistex
includes cinema and
press advertising based
on 'The Kiss of Life for
Lips' theme.
A counter display unit
to hold all four products
-Blistex Lip Cream SPF
6, Blistex Ultra
Protection Balm SPF 30,
Blistex Lip Conditioner
SPF 15 and Blistex
Lip Tone SPF1 5-
is also available to
retailers.
Aimed at 15-24-
year-old females,
the 30-second
commercial will
alternate
fortnightly with
the Blisteze
commercial from
I ictobct until
March. Advertising
will be targeted at
the same magazines as
Blistex. A red 'X' will be
used on the counter
display unit and
showcard.
Dendron is hacking the
product manager
Amanda Byrne says:
"This high-impact
consumer campaign will
increase the visibility of
Complete across the
country. We believe
many soft contact
lens wearers still
need to be told
about the benefits
of the one-bottle
system. As
Complete is
available only
from opticians or
pharmacies,
pharmacists
should take full
advantage of the
campaign by stocking up
now and ensuring
Complete is highly
visible to customers."
Allergan Ltd. Tel: 01494
444722.
Water Gem for DIY filtering
Aqua Cure, one of the
UK's specialists in water
purification, has
launched a unique DIY
home water filter system
in response to
consumers' health
concerns about domestic
water quality and safety.
Water Gem is a ready to
fit water filter kit, which
can be easily installed to
the domestic sink to
provide clean, filtered
water at less than one
penny per litre. The filter,
approved by the Water
Research Council, is said
to improve the taste and
smell of tap water by
filtering out sediment, dirt
and rust, and reducing
levels of chlorine,
chemicals, herbicides
and pesticides, as well as
inhibiting scale.
Water Gem retails at
around £49.95 with a 12-
month supply of easy-fit
replacement filters at
£29.95 for two. The
replacement filters are
also compatible with
most other makes of
domestic filter systems.
The Water Gem comes
with a three-year
guarantee for all parts,
excluding the
replaceable filter and the
company also provides a
free helpline number for
customers. Further
information on the
product can be obtained
by dialling Freefone 0800
627627 and asking for
Water Gem.
Aqua Cure pic. Tel: 01704
501616.
publicity package with a
pharmacy competition
based on matching lips
to famous faces. The first
correct entry opened on
October 1 1 will win a
midi hi-fi with 48
runners-up receiving £30
Marks & Spencer
vouchers.
Dendron Ltd. Tel: 01923
229251.
(MUST & DRUGGIST 20 JULY 1991
• © « • 9
From Practice
i ••••»•••« •••••••••••••••••••••••
Win a
major prize
Is the professional service you offer from your
pharmacy moving with the times? If you can relate
how you are forging links with other healthcare
workers, the Glaxo ^JeWcome/ Chemist & Druggist
Community Pharmacy Award offers you an
opportunity to win a major
he way primary care is
delivered is changing
fast. The demarcation
lines between the
»sffe?o, healt h professions are
breaking down and community
pharmacy practice is adapting to
the changes local purchasing is
bringing.
With this in mind, we want you
to tell us how you are forging
links with other health profes-
sionals to the benefit of patients,
others in the primary care team
and your own business.
You can enter the award if you
practise as a community pharm-
acist anywhere in the UK. You
should explain, in an essay of
The closing date for entries is
July 31, 1996.
The judges
I 00(1 woids, how I he liaison you
have forged was conceived, how
it operates and the benefits it
delivers.
The following examples may
serve as a guide to pharmacists
wishing to enter:
® you may be liaising regularly
with your local GP practice to
provide prescribing advice or
diagnostic services
• you may be co-operating with
hospital pharmacists over med-
ication for patients when they
are discharged
9 you may operate clinics, eg for
diabetics, or offer services in
conjunction with other health
workers.
You may include practice
leaflets, other relevant literature
and photographs to support your
entry and illustrate an aspect of
the service you offer.
Entries will be judged by a panel
of five judges. Glaxo Wellcome's
Dr Maureen Devlin and C&D's
editor, Patrick Grice, will be
joined by:
@ Ian Carruthers, chief execut-
ive of Dorset Health Commission
• Georgina Craig, who is the
head of professional devel-
opment at the National Phar-
maceutical Association
@ Gill Hawksworth, a comm-
unity pharmacist and member of
the Council of the Royal Pharm-
aceutical Society.
The prizes
The opportunity to attend one of
the major conferences or man-
agement courses listed below
will be offered to the three
winning entries.
• FIP 1997
• Career Management Course
( Raeburn & Keslake)
• Managing Teams
( Management Centre Europe)
• Managing People (Manage-
ment Centre Europe)
• Strategic Decisions (Ashridge
Management Centre)
• ASHP Annual Meeting '96,
San Diego, US.
Please complet e the entry form below and attach it to the front of your entry. Send the complete
entry to 'From Practice to People', Chem ist & Druggist, Miller Freeman Professional, Miller
Freeman House, Sovereign Way, Tonbridge, Kent TN9 1RW.
Name..
Registered Address
Pharmacy Address (if different from above)..
Postcode Telephone.
Prizes in order of preference:
1
1 Entry is open to any pharmacist on the
Register of the Royal Pharmaceutical
Society of Great Britain or the Phar-
maceutical Society of Northern Ireland,
and who practises in the UK.
2 The winning three entries as
determined by the judges will be offered
the opportunity to attend a major
conference or recognised business
management course with all expenses
paid. No cash alternative will be offered.
3 The closing date for entries is July 31,
1996. The Award winners will be
announced in Chemist & Druggist on
November 9. Individual winners will be
notified by post by October 10.
4 The entry form below must
accompany an essay of up to 1,000
words setting out how and why the
entrant considers the professional
liaison developed by her or his
pharmacy practice has improved
healthcare provision to patients;
benefited the business; and improved
inter-professionallinks.
; Practice leaflets, patient literature,
photographs • and other supporting
material Tnay be submitted with the entry.
5 Entries should be typed or printed.
6, The entry, and supporting material
may be used editorially within Chemist
6 Druggist, G&D cannot give an
absolute guarantee that entries will be
returned in their entirety, although
every effort will be made to do so.
7 Winning entrants should be prepared
tn write an article for publication ol up
to .1,000, words on the eortference/-
j:bu§iness course/study tour they attend.
8 The decision of the judges is final. No
correspondence will be entered uiu>.
CHEMIST &DRIGGIST 20 JULY 1996
COUNTERPOINTS
Eve Taylor claims
in
pharmacies
Eve Taylor is launching its
aromatherapy retail product range to
over 14,000 pharmacies on August 1.
Pure and blended essential oils
will be made available to the
pharmacy sector under the label of
Face Care, Body Care, Specifics,
Bath Oil, Hydrogels and
Environmental Fragrance. Prices
range from £4.50 for the facial
cleansing brush to around £15 for the
environmental fragrancing kit.
Face Care will incorporate five
products, No1 to No5, designed to
help dry, sensitive, spot-prone and
mature skin.
3ody Care will consist of three
products, No10 to No12, blended to
stimulate and relax skin
imperfections associated with fluid
retention.
The Specifics range includes three
products (301 to 303) designed to
assist the skin in its regenerative
cycle. Specific 303 is recommended
for scar tissue and stretch marks.
Included in the Bath Oils range are
six different oil-blends labelled
stimulating, relaxing, toning,
balancing, revitalising and soothing.
Produced specifically for the retail
market is the Moisturising Hydrogel
range - Corelle, Citrelle and Astrelle,
a facial cleansing brush and an
Environmental Fragrancing range.
The range consists of four kits
energising, soothing, revite and
refreshing - designed to release the
vapour of blended oils through a clay
diffuser.
On-going support for the launch
includes package brochures with an
ingredient listing and application/-
usage chart/guide, a sampling
promotion and free product training.
Pharmacies will be able to contact a
helpline to obtain information for
guidance on product specification,
skin problems and ailments.
Eve Taylor (London). Tel: 01733
321101.
Collection 2000
Collection 2000 has created Shine
Time 2000, a high-fashion look for
autumn '96, combining shades of
lilac, mauve, pearl, blue and silver.
Fashionable combinations includi
the Eyeshadow Trio No 97 (SI. 29),
which consists of Mauve Sheen,
Merlin and Flamingo Pink; or
Quartet Eyeshadow No 7!). leal m ini:
Seahaze, Diamond IJlue, Light Blue
and Snowflake. A suitable lipstick
for the look is ( lollection 2000 Lip
i daze in < )rchid < lem (No 7) (SI. 15).
( lollection 2000 products are nol
tested on animals.
Collection 2000 Ltd. Tel: 01695 50078.
From A to Zinc with Arkopharma
Arkopharma, the herbal
medicine manufacturer,
has launched a new multi-
vitamin and mineral
product - Azinc Complex
capsules.
The sugar-free product
contains the recommended
daily allowance of a range of
vitamins and minerals from
'A to Zinc'. These include
beta-carotene (a precursor of
vitamin A), vitamin C,
vitamin E, vitamin B6, iron,
magnesium, zinc, copper,
folic acid and others. A pack of
30 capsules retails at S3. 65.
The new product has multi-
coloured and white packaging
to ensure on-shelf impact.
Arkopharma says the
supplement is "particularly
effective for tired, stressed,
overworked people; those
who are slimming and have an
unbalanced diet; or those who
are regularly taking part in
sporting activities".
Arkopharma (UK) Ltd. Tel: 0181
763 1414.
* 5 c °™ Caps
removal
,,ls 'an/ Reset
\ \ r\ £ 'fectri/e
t savers
for Profit.
Summer Season Sales
History shows both you and your customer alike
can trust a product bearing the Carnation name.
With this proven heritage Carnation Footcare
.'ill help to make your sales grow.
• 33V3% Profit on return
• Full consumer advertising
support throughout peak
season beginning June '96
75 years of proven pharmacy sales
ARNATION
Avail-able in packs ol 5 01 10 tram yon
English Circuns representativi
ABRIDGED INFORMATION. I EGA1 CATEGI IRY; I iSI INI Ml ATI! INS: l-oi the ri'iiinvnl «l hard. ■ ACTIVE INGREDIENTS: Sain ylu A, id BP 4.'".
PRODUC1 LICENCE HOLDER: I uxson I Icrrard & I pany I imiU'd, 125 IWtwi-ll R.»id, ' >l.ll.ury, Warley, VK-m Midland*, B6 l ) 4BI li-l 0121 544 7117
FURTHER INFORMATION FROM THt I ICENl I HOI DUR is AVAILABLE ON REQUEST.
CHEMIST & DRUGGIST 20 JULY 1996
85
COUNTERPOINTS
Strong growth in
sun care sales
The growing number of
people taking sun
holidays, and the hot
summers we have
experienced in recent
years here in Britain, have
contributed to strong
growth in the sun care
market, thought to be
worth £136 million.
A new market report
from Datamonitor reveals
that increased growth is
coming from new product
developments, particularly
in the high-protection area,
and that high sun protec-
tion factor (SPF) items
have increased their share
of the sun care market. Sun
protectors with an SPF of 7
and above now account for
48 per cent of the sun
protection segment, while
the share of SPF 0-3s has
almost halved from 15.5 per
cent in 1991 to its presents
per cent.
L'Oreal's Ambre Solaire
is the market leader with
a 5 per cent lead over
Boots' Soltan.
UK Skincare' is
available at a price of
£495 from:
Datamonitor Europe. Tel:
0171 625 8548.
Dazzling campaign for Colgate Platinum
Colgate-Palmolive is
adopting a dazzling
white theme for its
integrated PR and
press campaign for
Colgate Platinum, its
whitening toothpaste.
All the activity is
being targeted at women
and includes
advertorials in high-
profile women's titles,
such as Vogue, Marie
Claire, Cosmopol ita n
and Elle. The
advertorials focus on the
"whitening benefits
which combine with the
great taste to promise a
pearly white, confident
New 2 in 1 available for Synergie
Synergie is building on its
success in the cleansing
market with the launch
of a new combination
cleanser and toner.
Synergie Refreshing
Gentle Cleanser Milk +
Toner offers the
efficiency of a milk and
the benefits of a toner
in a one-step,
hypoallergenic
formulation.
The active ingredients
inc lude mango oil, rich in
essential fatty acids,
which is easily absorbed
by the skin to soften it.
Vitamin E is added for its
antioxidant properties,
which the company
claims helps protect the
fatty membranes of the
cells, delaying the
appearance of fine lines
and wrinkles.
Synergie Refreshing
Gentle Cleanser Milk +
Toner is available
nationwide from August,
retailing at S3. 19 for a
200ml pack.
Laboratoires Gamier. Tel:
0171 937 5454.
Rapping with Ricola: going Alpine in Atlanta
Ricola, the medicated
herbal confectionery
brand, is spending £5
million on marketing
support, which kicks
off this summer with
a heavyweight tele-
vision campaign set
to run throughout
Eurosport's satellite
coverage of the forth-
coming Olympics.
Valued at SI. 6m,
the initial Olympic
campaign will be
televised daily bet-
ween July 20 and
August 4, and is expected
to reach 1.2 million
adults every day. The ad,
featuring a futuristic rap
group who solve their
vocal problems with
sugar-free Ricola, is a
departure from the
traditional Alpine
image.
Ot her marketing
support includes
public relations
activity, point of sale
material and space-
saving pre-packed
counter display units,
available from
leading wholesalers.
Cedar Health Ltd. Tel:
0161 483 1235.
Braun improves comfort factor d !!kpi! system
Next month, Braun is
launching a further-
improved Silk-epil hair
removal system, called
Silk-epil Comfort, which
combines two new
product features for
enhanced comfort.
Smaller tweezers are
designed to provide
gentler epilation by only
gripping the hair to be
removed, avoiding the
unnecessary pulling and
dragging of the
surrounding hair and
skin.
Bigger feed-in combs
smooth a larger area of
the skin in preparation for
the treatment, which also
enhances comfort.
Silk-epil Comfort EE110
for Legs (£49.99) offers a
choice of four settings,
adjustable tweezer grip
for normal or delicate
hairs and Silk-epil After
Epilation Moisturising
Cream.
The Silk-epil Comfort
Body System (£49.99), an
extension of the leg
system, is an epilator with
an interchangeable head.
The tweezers can be
replaced by a shaver for
use on more sensitive
areas, such as the bikini
line or under the arms.
Braun (UK) Ltd. Tel: 01932
785611.
smile and fresh
breath".
Supporting the
advertorials, press ads in
the same premium titles
use a fashion theme to
convey the 'teeth have
never been so white'
message. Models
dressed in expensive
white designer clothes
wear an affordable white
smile attributed to
Colgate Platinum.
To ensure the 'white'
message hits home,
cinema and video
advertising will run
through July and August.
Colgate-Palmolive Ltd.
Tel: 01 483 302222.
Chocolate selection from Bourjois
The autumn/winter colour
collection from Bourjois
is a palette of chocolate-
coloured shades for eyes,
cheeks, lips and nails.
Available from
September 4, the Bruns
D'Automne collection
spans the spectrum from
Beige Rose Pastel
Lumiere Eyeshadow
(£3.95), a light iridescent
beige, to Pastel Naturel
Matt Eyeshadow in new
Chocolat (£3.95), a rich
mocha brown.
New shades in Pastel
Joues Blusher (£4.75) are
Chatagne Doree, a
shimmery bronze brown,
and Santal, a coco brown
with a hint of iridescence.
Bourjois Ltd. Tel: 0171 436
6110.
ON TV NEXT WEEK
Alberto-Culver V05: STV, C, A, HTV, W, C4 + satellite
Alka-Seltzer: GMTV, C4 + satellite
Andrews: All areas
Aquafresh toothpaste: All areas
Centrum: All areas
Colgate-Palmolive Soft & Gentle: All areas
Colpermin: M
Gentle Touch: All areas
Dettol Antiseptic spray: All areas, except CTV, C4, TSW
Gentle Touch: All areas
Gillette Natrel Plus: All areas, except LWT and GMTV
Hedex Ibuprofen: All areas
Macleans Bicarbonate of Soda toothpaste: All areas
Nicotinell gum (trial pack): STV, B, G, Y, HTV, LWT, TT, C4
Nurofen: All areas
Oil of Ulay: All areas
Pantene: All areas, except GMTV
Radox Wheatgerm: All areas
Rimmel: All areas, except U
The Wrigley Company/Sugar Free Brands: All areas
Total: All areas
Wella Experience: All areas, except CTV
Wrigley's Orbit (Improved): All areas
GTV Grampian, B Border, BSkyB British Sky Broadcasting,
C Central, CTV Channel Islands, LWT London Weekend,
C4 Channel 4, U Ulster, G Granada, A Anglia, CAR Carlton,
GMTV Breakfast Television, STV Scotland (central),
Y Yorkshire, HTV Wales & West, M Meridian, TT Tyne Tees,
W Westcountry
C'9
CHEMIST & DRUGGIST 20 JULY 1996
...In fact, a massive £1.7 million in only six months
We're investing hugely in the Blistex brands
throughout the 6 months from September
'96 with a lipsmackin' campaign including...
Dlistex
ceptional national cinema commercial with 'The Kiss of Life for Lips' theme
citing heavyweight press campaign in the young female magazines with
stunning full page, high-visibility ads.
tremely impactful point-of-sale including eye-catching window displays.
All this adds up to a major Xtra push for Blistex - giving a new
Kiss of Life to your profits!
For moisture, protection and everyday lipcare
PHARMACYupdate
Drugs in sport
How some formulations can be
abused to enhance performance
Remember the 1988
Olympics being
overshadowed by the
discovery that the
world's fastest man, Ben
Johnson, had anabolic
steroids to help him
across the finishing line?
Well, in this Olympic
year, Glasgow
community pharmacist
Stephen Kayne takes a
look at what is and isn't
banned for athletes
The use of performance
enhancing drugs in sport is
not new. In 1865, canal
swimmers in Amsterdam
were accused of taking a
mixture of heroin and
cocaine, and in the ea r ly
years of this century alcohol
and strychnine were taken by
boxers and a marathon
competitor.
Top athletes are often so
caught up with striving for
that extra margin of success
that they may resort to any
method that seems to bring
this goal nearer. In some
countries, drug abuse in sport
may be routinely
incorporated in elite training
programmes.
At the British
Pharmaceutical Conference in
London two years ago, the
audience sat spellbound as an
East German doctor
systematically catalogued the
programme of drug abuse
that had been promoted by
the authorities in his country
before the fall of communism.
He explained the practice of
'drug holidays' where athletes
ceased to take drugs at set
periods before competition so
that the risk of detection was
minimised.
Much of the initial work on
drug testing in sport was
accomplished by a
pharmacist-run laboratory at
King's College, London,
where an International
Olympic Committee-
^ Needle exchange ^ Research digest
Pharmacy-based needle exchange (IffS Predicting incorrect inhaler te
Pharmacy-based needle exchange
schemes come under scrutiny IV
Jicting incorrect inhaler technique to
reduce morbidity and mortality VII
accredited drug testing
service is provided for many
national and international
meetings'.
Of the many classes of
drugs available only a relative
few have been implicated in
enhancing performance or
masking the use of banned
drugs, and consequently
placed on a banned or
restricted list by the IOC. Here
are some of the more widely-
abused drugs.
Stimulants
Amphetamines
Amphetamine sprays were
originally prescribed for the
treatment of nasal congestion
(through vasoconstriction).
They are powerful central
nervous system stimulants
and have been taken to
increase the heart rate and
allay inhibition before
competition. Amounts of 14-
21mg of amphetamine
administered two to three
hours before an event have
been shown to improve
performance in three-quarters
of a sample of swimmers,
runners and weight throwers .
The drug causes blood to
flow from the skin and is
particularly dangerous during
intense exercise in hot
climates. There are numerous
reports of cyclists suffering
fatalities after taking
amphetamines.
Cocaine
Amphetamines have largely
been replaced in sport by
cocaine, the regular use of
which can lead to anxiety,
agitation, insomnia and,
ultimately, coronary occlusion
and death.
Sympathomimetics
Adrenaline and the
sympathomimetics,
ephedrine and isoprenaline,
are also considered to be
stimulants and are banned.
These compounds have
many therapeutic
THE COLLEGE OF
PHARMACY PRACTICE
This course (module 22), in
association with multiple
choice questions being
published in c&d august
10, provides 1 hour of
continuing education
|]:*I3HIIW
To be aware of the problem
of drug abuse in sport
To recognise drugs on the
banned or restricted list
To understand how drugs can
enhance performance in sport
To be aware of OTC banned'
and allowed' drugs
applications, notably in the
treatment of asthma, and
together with some of their
derivatives (for example,
pseudoephedrine and
phenylpropanolamine, etc)
are often present in the
formulas of OTC medicines,
too - Aller-eze Plus, Lemsip
Cold Relief and Day Nurse all
contain banned ingredients.
Salbutamol and terbutaline
are permitted, subject to
written notification by the
team physician, but they may
only be administered by
aerosol. Sodium
cromoglycate, used mainly to
treat allergic asthma, is also
allowed.
Caffeine
Caffeine produces a mild
central stimulation. Maximum
urinary levels of 12mg/ml are
set by the IOC.
The drug is claimed to
counteract the reduction in
performance caused by
fatigue and is popular in
rallying, particularly at night.
It is thought to work by
enhancing fat utilisation, thus
sparing glycogen '. As few as
Continued on Pll
CHEMIST & DRliWilST 20 JULY 1996
I
Continued from PI
four cups of filter coffee or six
cans of a famous cola drink
may cause a positive dope
test.
Anabolic steroids
First used in 1954, anabolic
steroids are mainly
chemically-derived
alternatives to the natural
male hormone testosterone.
They are designed to separate
the anabolic and androgenic
features of the hormone and
to improve its availability.
The drugs achieved
spectacular notoriety at the
Seoul Olympics in 1988 when
Ben Johnson's gold medal
was withdrawn after he tested
positive for stanozolol.
Anabolic steroids constitute
nearly half of all positive
samples detected by IOC-
accredited laboratories. They
are used to increase muscle
mass, especially in the
presence of high protein
intake, as well as improving
power and speed after
intense physical training.
There is some discussion as
to whether they act directly
on muscle tissue or whether
they encourage muscle
development indirectly by
helping prolonged exercise.
Performance may be
enhanced by increased
erythrocyte formation
allowing an increased oxygen
uptake.
Side-effects include hepatic
malfunction, coronary heart
disease, cancer, sterility and
uncontrolled aggressive
behaviour 4 .
An increased incidence of
tendon damage has also
been noticed among athletes
taking anabolic steroids due
in part to competitors
neglecting accepted
techniques within their
chosen sport.
Clenbuterol is a banned
compound related to the
anabolic steroids that was 'in
fashion' for a time. It has
been shown to stimulate the
deposition of body protein in
animals.
However, drug testing has
not proved to be foolproof.
British athlete Diane Modhal,
who originally tested positive
for testosterone, was later
cleared because of possible
false results due to
degradation of sample.
Beta-blockers
These drugs are used to
lower blood pressure and
slow the heart rate. Although
they reduce the ability to
perform physical exercise
and are therefore not the
subject of drug testing in
endurance events, they help
allay anxiety and steady the
nerves, and therefore may
help competitors in archery,
darts, shooting, bowls and
snooker. Side-effects include
cold extremities, fatigue and,
in extreme cases, heart
failure.
Diuretics
Diuretics are sometimes used
where a specific weight is
needed - for example, with
jockeys and boxers. Diuretics
shed weight quickly by
excessive water loss and by
acting as a blocking agent to
dilute urine and therefore
prevent detection of drugs in
other sports. Compounds
such as acetazolamide,
amiloride and triamterene are
banned.
Narcotic analgesics
Included in this class are a
number of drugs related to
morphine. They are used as
moderate to severe
analgesics.
The IOC Medical
Commission believes there is
evidence that these
compounds have been
abused in sport and, as there
are many other non-narcotic
drugs available, they should
be banned. Over the counter
products containing codeine
should not be offered to
athletes.
Most of these drugs have
major side-effects, including
respiratory depression and
dependence.
Dextromethorphan and
pholcodine are not banned
and can be used as
antitussives.
Peptide hormones
Human growth hormone
(hGH) is naturally produced
by the body to invoke
maturation and physical
development. It is now
produced synthetically and
may be used to increase body
mass. Some male athletes
use hGH to stimulate
testosterone production,
increasing aggression and
competitiveness. As yet it is
undetectable.
A reverse approach is to
use brake drugs, which are
generally hormonal and are
used to block physical and
sexual maturation. They are
very popular with female
gymnasts.
Other banned substances
include human chorionic
gonadotrophin 5 ,
corticotrophin (ACTH) and
erythropoietin (EPO).
The latter, a genetically-
engineered substance,
mimics the effects of training
at high altitude by regulating
the synthesis of erythrocytes,
but in excess can cause fatal
blood clots. Five years ago,
the drug was blamed for the
death of 18 German cyclists
from circulation problems.
The drug disappears rapidly
from the body and detection
has proved difficult in the
past, but recently a new test
has been announced.
Other drugs are subject to
certain restrictions. For
example, alcohol and
marijuana are not banned,
Table 1: an example of a homoeopathic sports first aid kit
Abrasions- superficial:
Calendula ointment/cream
Anxiety, excitement:
Aconite (terror), Arrogant nit (anxiety)
or Gelsemium (worry)
Bruising:
Arnica ointment
Colds and flu:
Gelsemium, Nelson's Coldenza,
Weleda's Infludo
Cough:
Bryonia cough linctus (Nelson's)
Diarrhoea:
Argent nit (from anxiety), Arsen alb
tablets
Insect bites:
Apis (stings) or Ledum (bites) tablets
or pyrethrum spray
Mental and physical tiredness: Arnica
Motion sickness:
Cocculus (or Nelson's travel sickness
remedy)
Soft tissue injuries:
Ruta tablets or ointment
Sunburn:
Cantharis tablets (or Nelson's Burn
ointment)
Trauma:
Arnica tablets
but the presence of both can
be tested. There are
restrictions on the use of local
anaesthetics and
corticosteroids.
Pharmacy advice
Pharmacists must be vigilant
when recommending OTC
remedies. This is particularly
important for elite and sub-elite
athletes who may be subject to
drug testing during training, as
well as competition.
Sports Councils in the UK
produce handy cards listing
the banned classes of drugs
with examples, and a supply
is available for customers.
There is also a compre-
hensive guide available,
entitled 'Drugs and Sport'. It
details all the banned and
permitted products.
Another solution is to
recommend complementary
remedies. The Sports Council
warns that some herbal
preparations may contain
banned substances from
naturally-occurring plants. For
example, ginseng root does
not contain banned
substances, but it is known
that marketed tablets (tablets,
solutions, teas, etc) bearing
the name 'ginseng' may
contain other undeclared
ingredients, such as
ephedrine. The Olympic
sprinter Linford Christie took
ginseng some years ago and
subsequently tested positive
for a banned substance.
There is no requirement for
a comprehensive listing of
ingredients in nutritional
supplements making it
difficult to determine whether
doping regulations are liable
to be breached.
No such risk is involved in
recommending homoeopathic
remedies and they are not
subject to any IOC controls.
There is a range of about 30
generic remedies known as
'polychrests' that have a wide
spectrum of activity and can
be administered to
sportspersons safely and
effectively, without affecting
any concurrent or subsequent
treatment. Table 1 offers
some suggestions for treating
common problems.
Discussions are in progress
with the British Association of
Sports Medicine to identify
how pharmacists'
contribution to sports care
can be increased.
References available on
request.
C&D is accredited by the
College of Pharmacy Practice
as a provider of distance
learning material until
December 31, 1997.
II
CHEMIST ft DRUGGIST 20 JULY 1996
^ o re 2 ^ 5 7 '
j ™ s I \
> » £ _ 5 o g 1
; 1 1 s § s f
I Ifllfa
l s ™ a s s g ° '
^J: ^ c II c j| ]
3 u
a ~» S c E
QJ O V _ ^
?= "s ei a !
: 1 3 5 2 ? 5
^||«.J|;
i If lif| ]
! S c 8 I „, I
! i E £ 5 5 S»
! a || 8 3 f g
v * E
Hills
! a -E if> - o T
■illai
p c £ <u ^ -
■ ' D
a ; ?
1=*? §1=11 i
6 oj ct 11 ' I
^ - i s ■
I S E g
Amilamo
Amiloride HCl Oral Solution, 5mg/5ml, Sugar Free
New from Rosemont!
I '"ILOHIDE HWWOCHt**
ii ORAL SOLUTION
Potassium Sparing Oral Liquid
Now, when you have a patient who
requires a potassium sparing diuretic, hut
finds it hard to swallow tablets, you can
offer them a solution ■ Ajtiilamont
This is the latest addition to the
Rosemont range of oral liquids, and is
another unique product, being Britain's
only licenced, single ingredient,
potassium sparing diuretic, in oral liquid
form
Like many of Rosemont's products,
Amilamont™ is sugar free, to help
protect patients' teeth, it is suitable for
Rosemont's Specials Service
Under our specials licence we are able
to offer you bespoke oral liquids,
covering a wide range of therapeutic
areas in a variety of strengths
and sizes.
Naturally, the products from our
Specials Service are made to lull
pharmaceutical standards, and are
analysed and tested to ensure correct
and consistent quality.
These products can be supplied in as
little as 24 hours upon request.
Just call us on our
FREEPHONE : LIQUIDS LINE
0800 919312
diabetics and is pleasantly flavoured to
keep patients happy as well as healthy.
Right Strength, Handy Size
Amilamont™ is at a strength of
5mg/5ml, making if easy to administer a
standard dose*. It is available in a handy
125ml, tamper evident bottle, from all
major wholesalers
With Amilamont™ added to the
licenced liquid range, Rosemont
continues to give pharmacists a lop
quality way to treat patients, without
taking unnecessary responsibility..
*BNF March IHflli
Filled with confidence!
As Britain's oral liquid ROSGITIOnt'S
medicine specialists, Rosemont - ■ - -
are keeping at Hie forefront of HGW rllCfll Sp00O
production technology. DrOdUCtiOII line
Rosemonl has installed a complete new
filling line as part, of the multi-million
pound improvement to their
manufacturing facilities. High speed
bottle filling is combined with optimal
precision to volume, ensuring that high
quality liquids are processed into ready
to use products with the latest
technology.
Staff are sent, to Germany and Italy for
training in the operation and servicing of
one of the most modern filling lines
currently in use in the UK.
This major investment is part of
Rosemont's ongoing development,
programme, designed to ensure that, they
will continue to offer pharmacists and
patients the very finest range of oral
liquid medicines in the country.
< M % .
The new compounding fj|jp|
and filling line at-
Rosemont.
The LICENCED LIQUIDS
Current oral liquid medicines in the Rosemont range, fully licenced and prepared to
the highest quality standards:
• Nuslamont™ Nystatin Oral Suspension, 100,000iu/ml, Sugar Free - PL 0427/0)01
• Temazepam Oral Solution 10mg/5ml, Sugar Free - PL 0427/00X9
IBB ' IfE • Miihadose 1 " Methadone Oral Concentrate, lOmg/ml. Sugar Free ■ PL 0427/0098 Ais ,, I: ■ > „ / •
WKtJ^^ ' Amilamonl' ' Amitoritlv IICI Oral Solitlioi, inig/tiiul. Sugar Free - PL 0427/0091 //Of/ ((til I' (' I If (HI
Rosemont Pharmaceuticals Ltd.,
Rosemont House, Yorkdale Industrial Park, Braithwaite Street, Leeds LSI 1' 9XE Telephone: (01 13) 244 1400 Fax: (01 13) 246 071
PRACTICE
wop shop
Pharmacy needle exchange schemes are now
widespread thanks to their role in reducing the
transmission of HIV among injecting drug abusers.
Dr Rod Tucker, a community pharmacist and director
of the Freelance Needle Exchange scheme in North
East Lincolnshire, investigates how pharmacists can
make the most of the scheme
N'eedle and syringe
exchange is simply a
scheme enabling injecting
drug users to obtain free
sterile needles and syringes
in exchange for their used
ones.
Exchange schemes were
originally established in 1984
in Amsterdam, not in
response to the emerging
AIDS epidemic, but to the
growing problem of hepatitis
B among drug injectors.
Although the HIV virus had
been isolated as early as
1981, little was known about
its mode of transmission.
However, in 1983, blood
samples taken from drug
injectors in Edinburgh were
the first to show positive
antibodies to the HIV virus'
and studies of drug injectors
have since found that the
microtransfusion of blood
which occurs when drug
injectors share syringes poses
a significant risk for the
transmission of the virus 234 .
Moreover, it is known that
injectors will share spoons,
filters and bowls of water, and
communal use of such
paraphernalia is thought to
pose a risk in the
transmission of the virus 5 .
Government policy
The UK Government
responded quickly to the
issue of HIV prevention and,
in 1987, exchange schemes
were officially launched. The
remit of these exchange sites
was to issue injecting drug
users with sterile syringes, on
an exchange basis, so that
used injecting equipment
could be disposed of safely.
Before this official launch,
schemes to supply drug
injectors with clean syringes
had already been running
through various drug
agencies 6 .
In Liverpool, some
pharmacists were distributing
free needles, syringes and
condoms, and were accepting
back used syringes for safe
disposal'.
The sale of syringes by
pharmacists to known or
suspected drug misusers was
initially denounced by the
Royal Pharmaceutical Society
which, in 1982, had issued a
Council statement stipulating
that sales of syringes should
only be permitted for bona
fide customers for therapeutic
purposes. However, by 1986
the Society had lifted this
restriction and issued
guidelines for pharmacists
wishing to become involved
in exchange schemes 8 .
Aims of the scheme
In response to the growing
AIDS epidemic, the mid-1980s
saw a wider acceptance of the
concept of harm
minimisation. This
represented a pragmatic
approach to drug misuse and
involved two basic tenets:
reduce the risk to the
individual who injects drugs
and minimise the harm
associated with the misuse of
drugs.
In the context of harm
minimisation, needle
exchange schemes are
considered to be more than
simply a means of supplying
clean injection equipment.
They are a strategic response
to the potential rise in the
prevalence of AIDS and a
means of making contact with
as many drug injectors as
possible in an effort to
change their AIDS-related risk
behaviour, such as sharing
syringes and filters, for
example.
To achieve this aim,
exchange schemes need to be
in a position to offer a wide
range of drug paraphernalia,
such as medicated swabs,
tourniquets, sterile water and
filters. During the past ten
years, exchange schemes
have become accepted as an
important harm reduction
measure 9 ' .
THE COLLEGE OF
PHARMACY PRACTICE
This course (module 23), in
association with multiple
choice questions being
published in c&d august
10, provides 1 hour of
continuing education
Pharmacy-based exchange
schemes are designed to be
complementary to the
services offered by drug
agencies and should be
viewed as a means of making
contact with a large number
of clients and, if necessary,
referring those clients to drug
agencies where there is
access to advice and
counselling about their drug
use.
There are several reasons
why pharmacies should
provide needle exchange
services. Accessibility and
anonymity are key
advantages of community
pharmacies. Much of the
early needle exchange
research found that drug
injectors would not travel any
great distance to obtain their
syringes or 'works' and many
clients still feel there are
barriers to using agency-
based exchange schemes.
Pharmacies also tend to
have longer opening hours
and many are open on
Sundays. Moreover,
pharmacists are available to
offer advice about general
O To understand the principles
of needle exchange schemes
To be aware of Government
support for such schemes
C To recognise how schemes
can be put into practice
To recognise the aims of a
pharmacy-based scheme
To appreciate the associated
moral and ethical dilemmas
health matters and, provided
they respond to drug injectors
in the same way as any other
customer, a degree of trust is
soon built up.
Practicalities
Pharmacy needle exchange
schemes are now widespread
in the UK and the
Pharmaceutical Services
Negotiating Committee has
information about schemes in
over 60 unitary health
authorities", though in theory
every authority has funding
available. The pharmacy
schemes are often co-
ordinated by a local drug
agency, but in some areas the
health authority will appoint a
needle exchange worker. This
is sometimes a pharmacist
who can visit pharmacies
with training and advice.
Alternatively, as
pharmacists are the providers
of exchange services, it would
seem logical for them to
amalgamate and co-ordinate
the needle exchange scheme
themselves. This latter option
is the model for the Freelance
needle exchange scheme in
North East Lincolnshire. The
scheme is managed by
Continued on PVI ►
IV
CHEMIST &. DRUGGIST 20 JULY 1996
Excessive perspiration is
deeply embarrassing and
now we're telling
everyone about it?9
What if you couldn't find an
As many as 26% of all women asked
antiperspiranl that worked? What if were interested in buying a product
you went on sweating so much successfully used by doctors' - if it
that before the day was out you was available from their pharmacist,
needed a change of clothing? This is Clearly the market is there, and
the reality for a surprising number Driclor Solution is ihe brand to
of people, as a recent Gallup survey reach it especially once our
found. In fact, 11% of the women
edia campaign begins this
they spoke to were frequenth forced summer. \s a c
iperspirant
to change clothes or <o\er up ^
to avoid the embarrassme
Kcessive perspiration.
The level of dissatisfaction
with existing antiperspirants
might also surprise yon.
Driclor
SOLUTION
(Ontmrc Aluminium Chloride Htunhydiolo
A major
advance in
the treatment
of excessive
perspiration
Driclor Solution provides long
term control of excessive
perspiration, and even works
for problem sweaty feet.
Every pharmacist should
stock it. Now more than ever.
5
EFFECTIVE DRYING ACTION
• ICING LASTING EFFECT
• UNPERFIMT1
ROll OH APP1K ATOK
Pharmacy only clinical anli|>ci s|>ii ayS
Presentation: Solution \ctlvc ingredients: Aluminium Chloride Hexahydrate USP areas are completely «ir\ before application Do noi apply Driclor to broken,
20% w/w Uses: Driclor is Indicated for the treatment of hyperhldrosis (excessive Irritated, or recent l> shaven skin Dru inr may r.-msc irritation which maj be
perspiration) Dosage and administration: Apply Driclor lasi thing al night after alleviated by the use ol a weak, corticosteroid cream \void contact with the eyes,
drying the affected areas carefully Wash oil in the morning. Do noi re-applj the There are no restrictions on 1 1 ■ < - use ui Driclor during pregnancy or lactation. Avoid
^1 product during the day Initially the product may be applied each contact with clothing and polished metal surfaces. Product Licence Number:
5TIEFEL rii^hl until sweating slops during the day. Frequency of 0174/004'! Pack si/e and Retail Selling Price: 30ml bottle. £4.75. Legal
\ application may then be reduced to twice a week or less category: P. Date ol preparation: March 1995 Stiefel Laboratories (I'M Ltd.,
fterarch in Dermatology Contra-indieations, warnings etc: Ensure that the affected llollspur Lane. Wooburn Green, High Wycombe, Bucks, 11P10 0AU.
I
PRACTICE
J Continued from PIV
myself and another
pharmacist and we were
successful in our bid for the
needle exchange services
which were put out to tender
in 1993. Today, we have
ultimate control over
providing needle exchange
services in the region, liaising
closely with the local
substance misuse agency and
providing training for
pharmacists and information
for exchange clients.
The range of possible
equipment that can be
supplied through pharmacy
exchange schemes is listed in
Table 1. Some pharmacies
supply syringes loose while,
in other areas, equipment is
supplied prepacked.
Few of the pharmacy
schemes will supply filters,
tourniquets, citric acid or
sterile water since the supply
of such paraphernalia (other
than syringes and needles) is
an offence under the Misuse
of Drugs Act. In practice, it is
unlikely that the police, who
are generally supportive of
exchange schemes, will bring
about a prosecution.
Furthermore, the Code of
Ethics cautions pharmacists
on the supply of substances
"liable to misuse". The sale of
citric acid and supply of filters
or tourniquets could
constitute a breach of the
code.
There is considerable
variation throughout the
country in both the allocation
of funding for exchange and
how pharmacists are
remunerated. As a broad
generalisation, pharmacists
are paid a fee per issue,
whether that is a single
syringe or a pack, and an
annual retainer fee which is
paid for providing the service,
irrespective of the number of
exchanges made. The fee is
sometimes incremented on a
sliding scale and payments
vary between a maximum of
£6,000 per annum and a
minimum of £50 per annum.
Morals and ethics
There is a moral dimension to
the concept of supplying
syringes to drug injectors
which often presents
pharmacists with a dilemma.
To supply syringes would
appear to condone drug
misuse, whereas not to
supply syringes increases the
likelihood that drug injectors
will share syringes and hence
expose themselves to the risk
of HIV infection.
While this might be
perceived as the drug
injector's just desserts, the
Table 1: range of possible equipment
available through exchange
schemes
Various syringes (eg 1,2,5 and 10ml)
Medi cated swabs
Condoms
Intercobra tubes (to return used syringes)
Spermicides
Tourniquets
Sterile water
Citric acid
Cotton wool/filters
major route of transmission
of the virus is through sexual
intercourse and drug users
are known to be sexually
active and indulge in
unprotected sex' 1 . This clearly
has implications for the
spread of HIV into the wider
population and pharmacists
should bear this in mind
before rejecting the idea of a
needle exchange scheme.
There are also several
practical issues to be
addressed (see Table 2) and it
is well worth doing some
research into the drug
problems in an area to assess
the need for a needle
exchange service. Many of
these concerns can be
alleviated by talking to other
pharmacists who are
currently involved in
exchange schemes.
Shoplifting and physical
abuse are rarely a problem
(although they may occur)
and such actions are
perpetrated by the minority of
clients as most exchange
clients value the service and
are unlikely to act in such a
manner as to jeopardise it.
Another factor which poses
a problem is the risk of
needle-stick injuries. Existing
schemes will have a policy on
the use of sharpsafe boxes. It
is sensible to store such
boxes where they can be
easily accessed, but not
where they may cause
inconvenience (or risk) to
other members of staff or
public. Collection of the
sharpsafe boxes is normally
arranged by the local
authority.
If any pharmacist
does sustain an
injury, provided that
they have observed
the protocols
already in place, it is
unlikely that they
would be held
legally liable and
hence have to pay
compensation.
Furthermore, if a
pharmacist causes
an injury to a
member of the
public, then they
would be covered
by their insurance
(for example, NPA
insurance).
Alternatively, if the
pharmacist causes
injury to another
member of staff,
then they are
covered by the
employer's
insurance.
Pharmacists are
also strongly
advised to get
themselves and
their staff vaccinated against
hepatitis B.
Despite many of the
reservations that pharmacists
might have about needle
exchange schemes, the
majority who are already
involved find it is a satisfying
part of the extended role and
that it has not adversely
affected their business.
While the direct financial
rewards can be low (though
up to £6,000 per year is not
inconsiderable), in the longer-
term many of the exchange
users will use their exchange
pharmacy to collect their
prescriptions, so generating
greater revenue.
Pharmacists who are
interested in becoming
involved should contact their
LPC or the local drug agency
which will be able to advise
them on the availability of
services in their particular
area.
Future schemes
In the future it is conceivable
that pharmacists will become
more involved in the
provision of services to drug
misusers, including anabolic
steroid users. There are
already schemes in parts of
the country which involve the
supervision of methadone
and it is possible that
pharmacists could play an
even greater role in the
clinical management of these
patients.
The recently published Task
Force review on services to
drug misusers 1 ' foresees a
greater role for pharmacists,
and with the Government
Table 2: possible reservations of
pharmacists before starting needle
Increased shoplifting
Adverse effect on business
Staff objections
Risk of needle-stick injury
Threat of physical/verbal abuse
Level of remuneration
More needles discarded in the community
prepared to allocate
additional money for projects
related to substance misuse,
pharmacists should waste no
time in taking the initiative to
define how best they can
extend their role in the area of
service provision.
References
Mulleady G. A review of
drug abuse and HIV infection.
Psychology and Health
1987,1.149-63
2 Robertson J R, et al.
Epidemic of AIDS-related
virus (HTLV lll/LAV) infection
among intravenous drug
abusers. BMJ 1986; 292: 527-
29.
3 Wodak A, et al. Antibodies
to the immunodeficiency
virus in needles and syringes
used by intravenous drug
abusers. The Medical
Journal of Australia,
1987;147:275-76.
4 Chitwood D D, et al. HIV
seropositivity of needles from
shooting galleries in South
Florida. American Journal of
Public Health 1990,80(2): 150-
52.
5 Koester S, Booth R, Wiebel
W. The risk of HIV
transmission from sharing
water, drug mixing containers
and cotton filters among
intravenous drug users. The
International Journal on Drug
Policy 1991;1(6):28-30.
6 Lart R, Stimson G V.
National survey of syringe
exchange schemes in
England. Br J Addiction
1990;85:1433-43.
7 Anonymous. Liverpool
pharmacists supply free
needles and condoms. Pharm
J 1986; 237: 825.
8 Council Guidance.
Guidelines for pharmacists
involved in schemes to
supply clean syringes and
needles to addicts. Pharm J
1987;238: 481.
S Advisory Council for the
Misuse of Drugs. AIDS and
Drug Misuse Part 1. HMSO,
London 1988.
10 Advisory Council for the
Misuse of Drugs. AIDS and
Drug Misuse Update. HMSO,
London 1993.
11 Horridge G, PSNC.
Personal communication,
February, 1996.
12 Quirk A, Rhodes T,
Condom use by drug users:
whether, why not and how?
Executive summary No41,
CRDHB, London; 10995.
13 Task force on the services
for drug misusers, HMSO,
London, 1996.
C&D is accredited by the
College of Pharmacy Practice
as a provider of distance
learning material until
December 31, 1997.
Mi
CHEMIST & DRUGGIST 20 JULY 1996
Predicting
incorrect
inhaler
technique
Given that asthma and
chronic obstructive
airways disease cause
significant morbidity and
mortality, and that metered
dose inhalers are the
standard means of delivering
bronchodilator therapy, we
ought to know more than we
do about the ability of
individuals to use the devices
correctly. A group of US
pharmacists have, with Glaxo,
now addressed the problem.
They studied 29 people
attending hospital clinics who
were prescribed an inhaler for
the first time and 42 healthy
volunteers with little or no
previous experience of
inhalers. Their average age
ranged from 50 to 87 (mean
70). Each was given
standardised instruction on
inhaler technique using a
placebo device. Correct
technique was defined as
activating the device within
the first half of inhalation;
continuing to inhale slowly
and deeply; and holding the
breath at full inspiration.
Assessment of inhaler
technique was then correlated
with variables which might
influence performance.
Overall, 62 per cent of all
subjects could demonstrate
the correct inhaler technique
after instruction and 56 per
cent could still do so one
week later. There was no link
between the time taken to
learn the technique and
ability to use the inhaler
correctly, with half the
successful users needing 10
20 minutes and one in eight
needing 20 30 minutes to
master the device. Variables
that were significantly
associated with incorrect
technique included cognitive
impairment, male gender and
lesser hand strength.
Adjusting for hand strength,
those with cognitive
impairment were 3.7 times
more likely, and men were
five times more likely than
women, to have incorrect
technique. Factors that did
not predict incorrect
technique included
educational status and being
a patient or volunteer: those
with incorrect technique
tended to be older but this
was not significant.
These results are
informative: advanced age is
usually assumed to be one
explanation for not being able
to use an inhaler but, in itself,
this appears not be so.
Nonetheless, many of the
problems sometimes
associated with old age and
drug treatment in the elderly
- cognitive impairment, weak
hands - are important. It is
surprising that men were less
able to use inhalers correctly;
this may be due to poorer
manual dexterity compared
with women. The factors
identified in this study are
easy to use clinically as
indications that some patients
may need extra help with
their inhaler and they should
be borne in mind when
counselling patients.
Archives of Internal Medicine
1996;156:984-8
Insight into schizophrenia treatment
For many people with
schizophrenia, if they are
to live in the community
and carry on a near-normal
life, it is important that they
are encouraged to take their
medication. Yet discontin-
uation seems common,
resulting not only in symptom
recurrence but also disrupting
social and economic support.
One reason why affected
people may stop taking
antipsychotic medication -
apart from the adverse effects
- is that they may not believe
they need it. There is evidence
that only one-quarter of
people with a long history of
psychiatric illness believe they
are psychiatrically ill
In particular, people with
schizophrenia may not be
aware that they are ill, that
their illness causes
symptoms, or that they need
treatment. Whether this lack
of insight is due to
schizophrenia itself is
uncertain but it has been
linked with a belief that
treatment is unnecessary and
with a wish to stop
medication. Conversely,
patients with insight into their
problems are more likely to
co-operate with treatment.
Other factors which might
influence the decision to stop
treatment include knowledge
about schizophrenia and
intellectual functioning. How
they interact with insight has
now been investigated in 64
people with schizophrenia.
Their keyworkers (health
professionals designated to
co-ordinate care for
individuals) noted that nine
actively requested
medication, 40 passively
accepted it and 15 actively
refused treatment. Insight
was strongly correlated with
illness severity and chronicity.
Those who had actively
refused medication within the
previous two weeks had
significantly less insight than
those who had accepted it.
Insight correlated with years
in education and educational
attainment but not with IQ;
and education about
schizophrenia significantly
increased insight.
Although it is difficult to
define insight scientifically
(one definition of lack of
insight is disagreeing with the
psychiatrist!), it appears that
initiatives that improve
awareness and understanding
of schizophrenia should
improve continuation with
medication. Although
intellectual function (as
denoted by IQ at least) does
not appear to be relevant,
these initiatives must be
modified for people with
poorer education.
British Journal of Psychiatry
7996,168:7 18-22
CHEMIST & DRUGGIST 20 JULY 1996
VII
"ash incentives for prescribers
A cash incentive may or may
1 1 not encourage GPs to
I .^prescribe more cheaply
but it is only one of several
determinants of prescribing,
say researchers in Newcastle.
They surveyed local
practices after GPs were
offered an incentive scheme
to cut prescribing costs which
would have earned each GP
principal £1,000-£2,500 to
spend on approved
development projects.
In the former Northern
Regional Health Authority,
323 non-fundholding
practices completed a
questionnaire on the factors
that affected their prescribing.
Just over half reported that
they had tried to achieve
target savings. The decision
to achieve this was usually
reached within the practice,
though some said that
professional opinion and the
size of the financial incentive
were also important. Of these
practices, however, two-thirds
did not meet their target,
saying it was not achievable,
there was insufficient time or
the reward did not justify the
effort.
Medical and pharmaceutical
advisers helped 40 per cent of
practices with advice about the
incentive scheme. Most
practices decided to achieve
their targets by increasing
generic prescribing, but a third
reconsidered the duration of
treatment they prescribed and
a quarter increased recommen-
dations for self-medication.
Only 31 per cent said they
had a formulary or
prescribing policy, though
when one was in place
adherence to it was high.
Treatment guidelines were in
place in over 50 per cent of
practices for asthma, diabetes
and hypertension. The only
guideline that was
significantly more likely to be
found in practices which
achieved their targets was for
the management of ischaemic
heart disease. Guidelines
were more often followed
'usually' than 'always'.
Hospital practice is a
potentially important
influence on GP prescribing.
Schizophrenia, diabetes and
ischaemic heart disease were
identified by more than 50 per
cent of practices as conditions
for which prescribing was
usually or always hospital-
led. Around 40-50 per cent of
practices considered the
treatment of asthma, peptic
ulceration and hypertension
as predominately hospital-
led. Conditions least often
influenced by hospital
practice were contraception,
constipation, osteoarthritis
and acute infection.
British Journal of General
Practice 1996,46:287-90
Co-operation for a formulary
<n Ps who develop a
| ^-formulary benefit
U considerably from the
exercise - not only through
more rational and often
cheaper prescribing but also
by revising their knowledge of
therapeutics. However, the
process is very time-
consuming and often
unwelcome. Buying-in
someone else's formulary
avoids the work but leaves GPs
with no sense of participation
and little interest in keeping to
the recommendations.
GPs in South Bedfordshire
have investigated whether
these problems can be
overcome by sharing the
work among more GPs but
keeping the initiative local by
restricting it to the district.
From Bedfordshire's 350 GPs,
50 agreed to work together,
taking advice from specialists
and a pharmacist. They based
their work on three published
formularies and met once-
monthly to review products
for inclusion. The final
formulary, designed to meet
80 per cent of a GP's needs,
contained 179 drugs (72 per
cent generic) and delivery
devices from 12 therapeutic
categories.
The effect of the formulary
over three years was
evaluated by comparing
prescribing by the 50
participants with the 300 local
GPs who did not take part.
Generic prescribing increased
both among participants
(from 44 to 51 per cent) and
non-participants (40 to 48 per
cent). Significant changes
among formulary users
occurred in three therapeutic
categories: cardiovascular,
musculoskeletal and (for one
year only) obstetrics and
gynaecology. The number of
items per prescribing unit
increased by 11.8 per cent
among participants compared
with 14 per cent in non-
participants. Before the
implementation of the
formulary, participating
practices spent £1 1,000 less
on drugs than other practices
per quarter; afterwards, the
difference increased to
£51,000. The cost of
developing the formulary and
auditing its effects was
estimated at £70,000. It would
break even after six months.
It is difficult to identify
trends in prescribing practice
in that context but the
formulary appears to have
had a positive impact on
prescribing. The 50 GPs
involved spent £1.3 million on
drugs in the first quarter of
1994 and the authors note
that even small changes in
practice have a significant
impact on costs.
British Journal of General
Practice 1996;46:271-5
Antibiotics
in hospitals
/^Vver-use of antibiotics is one
|of the biggest problems
\J pharmacists tackle. It
wastes money; increases the
risk of antimicrobial
resistance; and increases the
risk of adverse reactions.
However, a seven-year study
from a Utah hospital shows
that, with effective
intervention, substantial
improvements in antibiotic
use can be achieved.
Activity data is routinely
recorded at the hospital,
providing clinical and financial
data which can be fed back to
prescribers via a
computerised information
system. The computer
software supports an expert
system which provides
computer-assisted decision
support and this was used to
develop consensus guidelines
on antibiotic prescribing.
Prescribers used the computer
model to rationalise their
treatment decisions. Each
received feedback on
prescribing decisions and this
was found to be critical to the
system's success.
Of the 162,000 patients
discharged from hospital 64,000
received antibiotic therapy.
There were significant
improvements in the quality of
surgical prophylaxis: the
proportion of patients receiving
their pre-operative dose within
two hours of surgery increased
from 40 per cent to 99 per cent
and the mean number of
prophylactic doses given per
patient decreased from 19 to 5.3.
Throughout this period,
prophylaxis was provided with
only three cephalosporins -
cefazolin, cefoxitin and
cefuroxime.
In 1986, prescribers' choice
and the computer guidelines
conflicted an average of 2.67
times per day and treatment
was changed in 30 per cent of
cases. By 1994, there was an
average of 1.32 conflicts daily
and 99.9 per cent were
changed to match the
computer's recommendation.
Annals of Internal Medicine
1996;124:884-90
PHARMACYupdate: distance learning for pharmacists
Pharmacists using Pharmacy
Update for continuing education
are reminded of the need to test.
With the support of Johnson &
Johnson MSD, C&D's readers
can self-test their progress by
using the multiple choice
question (MCQ) paper to be
inserted in the August 10 issue,
which will cover this week's
modules, together with those in
the July 6 issue. In other words:
« Malaria (20)
® Headaches (21)
• Drugs in sport (22)
® Needle exchange (23)
A faxback service for these
modules and associated MCQs
operates on 0891 444791
(premium rates apply). A
telephone marking service offers
independent verification of
results - details are given on the
monthly MCQ papers.
C&D in association with
^ o$wwn (Amen ° MSD
Consumer Pharmaceuticals
VIII
CHEMIST & DRUGGIST 20 JULY 1996
See what the
market leader
can do for you
Complete" is the market leader in the fastest growing contact lens
care segment. 1
Complete' is exclusively available to opticians and pharmacists
August national press campaign
Reference I Soft lens cold chemical Independent Market Research
COMPLETE
There is only one solution
Optometrists, like
pharmacists, are
m pallidal it lie if no lie ami
taking on the
management of minor
c.-fr coiiiidittions.
CfiristopSio Kerr, an
optometrist in south
London and consultant
ilo y,lie 1 yecaire
Information Service,
explains how guidelines
are being seu imgii io help.,
" ''--Acs, aii trends
in contact lens wear
As with pharmacists, the
expertise of optomet-
rists has perhaps been
under used until re-
cently. Poor communi-
cation between optometrists and
their medical colleagues has
blighted the development of the
Optometrie services in the t'K.
But times are changing.
In theory, the Opticians Act
and subsequent legislation re-
quires optometrists to refer all
patients with abnormal condi-
tions to their GP, without diagno-
sis. The OP then eithei treats the
patient or refers them for spe-
cialist or emergency help. The
optometrists' NHS Terms of Ser -
vice further reinforce these
responsibilities. It is, however,
some years since these protocols
were established and the quality
of optometiic education and
clinical ability have improved
considerably over the years.
It is now more widely accepted
that the optometrist is probably
best suited to treat a range of
common ophthalmic conditions
that do not require urgent refer-
ral to hospital. These conditions
demand a level of specialist
knowledge and instruments that
most GPs do not - nor wish to -
possess. In the interests of con-
venience to the patient and econ-
omy to the health service, many
'unofficial' arrangements have
evolved locally over the years.
Many optometrists have been
safely and effectively treating a
range of relatively minor and
often chronic conditions which
do not require acute manage-
ment. They are now keen to
advance their profession by
expanding their range of practice
in such areas.
With this in mind, Lambeth,
Southwark & Lewisham Health
Authority drew up 'Referral
guidelines for abnormal ocular
conditions', after extensive con-
sultation with optometrists and
GPs. Copies were distributed to
all optometrists contracted with
the health authority.
The guidelines list the main
eye conditions likely to be seen
in community practice and rate
(hem according to how quickly
they should be referred else-
where or whether the opto-
metrist could treat them. In gen-
eral we would take those listed
'urgent' as needing a specialist
opinion that day; 'soon' as need-
ing referral within a few days;
and 'in turn' implying that a 'new
patient' waiting time would be
appropriate. We arrived at the
range of conditions and referral
priorities after extensive discus-
sion and consensus.
Some examples are given on
page 91, in the hope that they
may help pharmacists decide on
the urgency with which patients
should be referred.
The document is for guidance
only and does not in any way
remove the rights of practition-
ers to make individual decisions
on individual cases. GPs were
fully briefed to ensure that the
introduction of the guidelines
received a harmonious welcome.
The cost of an ophthalmic out-
patient visit in the Lambeth,
Southwark and Lewisham area is
£70 a consultation. Any means by
which these expensive resources
can be more effectively used is
obviously in the interests of both
purchasers and providers, and,
most of all, the patients. The
guidelines are such a stratagem
and seek to give some consis-
tency in referral policy, in line
with the Patients' Charter
The scheme is now being
audited at the end of its first year.
Opinions of both optometrists
and doctors (GPs and ophthal-
mologists) are now being sought
as to its effectiveness in improv-
ing inter-professional communi-
cation and the more appropriate
use of ophthalmic resources. The
initiative has been enthusiasti-
cally welcomed and supported
by many concerned for the ulti-
mate benefit of the professions
and our service to patients.
Changing contacts
Contact lens research has led to
an entirely new concept - the dis-
posable lens.
As modern lens materials have
developed they have become
more and mor e like body tissues
or biocompatible, allowing the
wearer's eye to breathe naturally
beneath the lens. These delicate
materials are so well accepted by
the body that they eventually
wear and become contaminated
by cell products and, like the tis-
sues themselves, need regular
replacement. The contact lens
industry thus faced a problem: as
10
CHEMIST k DRUGGIST 20 JULY 1996
EYE CARE
Some examples
of the guidelines
Urgent referral
Acute glaucoma
Chemical injuries
Penetrating injuries
Retinal breaks and tears
Retinal detachment
Sight-threatening keratitis
Suspected temporal arteritis
Uveitis
Soon
Scleritis
Diabetic retinopathy
In turn
Ectropion (eversion of the eyelid
margins)
Entropion (inversion of the
eyelid margins)
Hayfever conjunctivitis in
children
Persistent blepharitis or
conjunctivitis
Severe dry eye
Optometrist managed
Chronic blepharitis
Chronic dry eye
Contact lens problems not invol-
ving serious corneal infection
Hayfever and allergic
conjunctivitis in adults
Sub-conjunctival haemorrhage
with normal blood pressure
Superficial foreign bodies and
ingrowing lashes
contact lenses became more and
more perfect they lasted for
shorter' and shorter periods!
However, the development of
sophisticated moulding technol-
ogy has reduced the costs of con-
tact lenses and made disposable
or frequent replacement lenses a
practical proposition. By fre-
quently changing their lenses,
wearers can avoid many of the
complications sometimes associ-
ated with contact lens use such
as infections and allergic reac-
tions. Disposable lenses are of
varying types which are dis-
carded after one day, one week,
two weeks or one month.
Success with all types of
lenses pr obably depends mostly
on the choice of practitioner, and
price is rrot always the best
guide. Anyone thinking of trying
contact lenses should ask friends
who wear lenses or their GP for
advice in selecting a competent
and conscientious practitioner
who will give ongoing care.
Fees are usually fairly low for
disposables; about £30 should
cover initial examination and fit-
ting, tuition, supply of die first
lenses and follow-up checks.
When t he practitioner is satisfied
that the lenses arc a success, the
client registers with the practice
and receives further supplies of
lenses for the next three or six
months. Monthly payments of
around £15-20 ensure a constant
supply. This fee should include
lens warranty or insurance, as
well as aftercare at regular inter-
vals, typically every six months.
These aftercare visits are vital.
Disposable contact lenses, if
properly maintained, have the
best safety record of any contact,
lenses yet developed Studies
have shown that they are about
four times safer than conven-
tional lenses in terms of compli-
cation rates. People who discard
their lenses daily need no lens
care solutions at. all. Those who
change their lenses less often
should still clean them every
night and store them in a disin-
fecting solution. But there is no
need for other time-consuming
cleaning routines such as protein
removal.
The contact lens practitioner
will recommend the most suit-
able solutions for' the lens mater-
ial prescribed. These will lie
products designed for soft rather
than gas permeable lenses. The
solutions must not be changed
without consulting the practi-
tioner. As well as the widely-pub-
licised risks of using products for
gas permeable lenses with soft
lenses, some soft lens materials
must be used only with specified
solutions.
( Irdinary soft lenses have an
average lifespan of one to one
and a half year s and cost about
£150. ( )vei this tune, frequent
replacement lenses usually work
out less expensive because the
higher cost of the lenses is bal-
anced by the reduced cost of
solutions.
Disposables also give specta-
cle wearers a chance to try con-
tact lenses cheaply for the first
time. No wonder eye care practi-
tioners are encouraging their
patients to throw away then-
lenses!
National Eye
Week 1996
This year's National Eye Week
will be September 23-29. Once
again the Eyecare Information
Service will create
opportunities for those who
wish to capitalise on the central
campaign.
The organisers say the week
will generate plenty of media
interest, so why not organise
your own in-store promotion,
providing customers with
information on eye care and
optical products, or featuring
Eye Week in a special window
display? Many manufacturers
will be supporting the event and
may be offering promotions or
discounts.
The EIS can supply leaflets on
a range of subjects. Tel: 0171
357 7730.
This year the focus of Eye
Week will be on image and
fashion.
NEW H ffl
ERADICATES SCABIES/ CRAB LICE t H
MAKE A DIFFERENCE, RECOMMEND WMSM
Liquid and cream shampoo, with malatflion
STAFFORD MILLER
DO3070 MAY 1996
Legal category: P Product licence holder: Ultra Chemical, Tubiton House, Oldham 0L1 3HS. Quellada is a registered trade mark. Further information is available from the distributor:
Stafford-Miller Ltd, Broadwater Road, Welwyn Garden City, Herts. AL7 3SP.
CHEMIST & DRUGGIST 20 JULY 1 996
91
EYE CARE
Keeping in contact
The increase in professional only' contact lews care products is likely to be of benefit to the pharmacist.
Adrienne de Mont looks at changing trends and the products which have evolved to meet them
■ l is vital for pharmacies to
I offer a full range of products
I if they wish to maximise their
I contact lens care business,
I says Allergan. Customers can
then buy everything they need
from the same place.
"It is also important that phar-
macies continue to make lens
care products prominently visi-
ble and accessible to customers,"
says Amanda Byrne, senior prod-
uct manager.
The total contact lens care
market is worth about ii 118 mil-
lion and is growing by 10 per cent
year on year. The optical sector is
increasing its share, estimated at
57 per cent ( up from 53 per cent
last year), while pharmacies are
declining slightly with 33 per
cent (from 37 per cent). Grocers
account for about 10 per cent. A
rapid initial growth in this sector
has stabilised at about 1 per cent
year on year.
Allergan says that the increase
in 'professional only' products is
likely to help pharmacies. The
company's latest disinfecting
products - Complete and Total
Care - are available only through
pharmacies and opticians.
According to Allergan, the seg-
ments are as follows:
• soft lens disinfection 52 per
cent (oxidative led by Oxysept,
soft lens cold chemical led by
Complete)
• surfactants 1 1 per cent (led by
LC-65)
• general lens care 10 per cent
(led by Total )
• salines 12 percent (led by Ciba
Vision)
• protein removers 7 per cent
(led by Ultrazyme/Hydrocare)
• wetting drops 1 per cent (led
by Lensfresh).
Peroxide systems dominate
the pharmacy market, but there
is a growing demand for one-bot-
tle systems for soft lens wearers.
These systems are by far the
fastest-growing segment, with a
70 per cent year on year growth.
They have had a big impact in
opticians but have yet to realise
their full potential in pharmacies.
"One-bottle systems now meet
GOLDEN EYE'
OINTMENT (0 1 5% w/w dibromopropamidine isethionate BP) I p I
DROPS (0 1 % w/w propamidine isethionate) l_E_l
"A sight for sore eyes"
New formulation as an ointment and new eye drops
Treats conjunctivitis, blepharitis and minor eye infections
<M> 50% on cost profit plus w/s discount
: Pharmacy Only guaranteed
Available from your wholesaler
^'ifSffLDEN EYE *
lOmi
Typhaim Limited 14, Parkstone Road, Poole Dorset BH5 2PG
Telephone (01202)666626 Fax (0t202)666909
a real need by lens wearers for
simple and convenient lens
care," says Ms Byrne. "Our Com-
plete solution has seen rapid
growth in pharmacy and has
been instrumental in increasing
the Allergan leadership position,
which now stands at 51 per cent
of the market. By stocking these
simpler to use systems, pharma-
cies can help to expand their
business opportunities."
The company is supporting the
Association of Contact Lens Man-
ufacturers in its bid to swell the
ranks of lens wearers. Only about
4 per cent of the UK population
(2.5 million people) wear lenses,
but the market is gr owing due to
competitively-priced lenses, easy
to use care systems and
increased advertising. It is hoped
the number of wearers could
reach similar levels to the IIS,
which is around 15 per cent.
Trends in contact lens use
obviously impact on the lens care
market. Soft lenses are showing
strong growth and disposables
have doubled their market share
in the past 12 months. Hard and
rigid gas permeable lenses are
declining in popularity.
The latest Target Group Index
Data shows that contact lens
wearers are predominantly
females aged 15-44 years. They
are most likely to be ABC 1 and in
full-time employment. There is a
strong regional bias towards Lon-
don and the South, although all
regions are expanding.
Consumer profiles have found
that contact lens wearers tend to
be outgoing, experimental, ad-
venturous and career-orientated.
The average user fits into one of
two groups: urban venturers who
are young adults with a high dis-
posable income living in major
cities, and affluent achievers
who are high income families liv-
ing in the suburbs and who own
two or more cars, eat out regu-
Easier to use systems have helped grow the contact lens care market
CHEMIST & DRUGGIST 20 JULY 1996
EYE CARE
Read the market
The OTC reading glasses market has changed since its introduction in 1989. But
rather than stocking large numbers of designs in all the powers, the advice is to
have a selection of good designs in a range of about six powers
Lil ly, go to the theatre and follow
investments closely. The former
lend to lie (luiuilimi and Inde-
pendent leaders, while the latter
opt tor The Times, Financial
Times and The Daily Telegraph.
• Revive, Allergan's new comfort
drops for soft lens wearers, is
hem" supported by lull-colour
advertisements m The Times,
Evening Standard and the Daily
Mail. The preservative-free for-
mula is based on carboxymethyl-
cellulose. A recent Gallup survey
reported that a thud o1 people
who give up wearing lenses each
year do so because of comfort
problems.
Another new product from
AUergan is Lens Plus Purite saline,
a rinsing solution for soft lenses.
The company says its telesales ini-
tiatives have encouraged bettei
merchandising and sell-selection.
This month's offer is a mixed case
of Oxysepl and Complete, with
POS material. Complete is being
supported by a S150,000 press
campaign in August .
Educational mater ial, including
the guide 'You and your contact
lenses', is available to pharmacy
staff to help them understand the
lens care products available
Rhone-
Poulenc
Rorer has
produced an
eye care
counselling
pack, which
includes
consumer
leaflets and
a poster
Avoid weird styles and do
not be tempted to stock
too many strengths of
reading glasses, com-
ments Direct Percep-
tion's Peter Philips.
Some frame designs will never
sell at any price, he says, as the
over-50s are unlikely to be happy
with anything too startling.
"We are selling to a more
mature inai kel and the designs
should be to their taste," he says
"Unfortunately, there are suppli-
ers with no optical background
who seem to import whatevei
they are offered providing the
price is right. That is why we see
so many weird-shaped frames
that might suit the US oi the Far
East but not the I IK.
"Some designs sell better than
others simply because they are
specifically designed for the UK
market. ( )ur search starts with an
analysis of optical sales arrd, with
t he help i if our panel i >f i >| it lcians,
we plan the shape and colour
very carefully on the basis of
these findings."
The better the designs, the
more facial types they fit. And the
smaller the stockholding, the
greatei the profitability from the
capital involved.
"No one can display 50 differ-
ent designs in all the powers.
This only produces confusion
and irritation for stockist and
customer alike," continues Mr
Philips. A range of six powers is
enough. Ranges with nine pow-
ers mean a 50 per cent larger
stockholding for the same sales
"What you need is a selection
from some good designs, well
made frames and lenses, in a well
thought-out range. You need lull
frames, half frames, metal and
plastic, economy ones and
smarter designs.
"Regularity of supply is also
important Do not get palmed ofl
with inferior substitutes that hap-
pen to be left on your suppliers'
shelves."
The ( )T( ' reading glasses mai
kel has changed considerably
since il began in IMS!). Many opto-
metrists offer budget ranges of
spectacles, after being motivated
by NHS changes arrd the intro
duction o1 readymades. This has
shown up some of the expensive
ranges as overpriced and has
damaged then sales, says Mr
Philips
He calculates that the iead\
made market could be worth
about £53 million, based on an
estimate of 22 million people
aged 45 years and over. Although
not everyone uses readymades,
others make multiple purchases
at an average price of So' a pair.
About 6 per cent of sales go
through non-optical outlets.
Eyecare Products estimates
that the self-selection reading
glasses market is nearer S22m.
About one-third of sales are
Boots own-label, one-third goes
through other pharmacies and
the remainder through supermar-
kets, department stores and
other independent outlets, in-
chiding opticians
There are about 24.5m people
in the UK with presbyopia, the
company says. ( )nce someone
has started using reading glasses,
he or she will change them for a
stronger magnification every two
to three years. So the market is
growing rapidly with the ageing
population.
In Japan and the US - the
world's most developed self-
selection readers markets - it is
not uncommon for consumers to
have six or more pairs in various
locations (home, office, car, etc),
so they are never' far away from
their glasses.
Consumer buying patterns are
spin between considered pur-
chases and emergency/impulse
buys which are needed when the
usual, often prescription, glasses
have been left behind.
The latter often triggers further
purchases as consumer satisfac-
tion w ith self-selection readers is
high, particularly as they start at
prices well below the eye-test
fee.
"Independent phai mai ies are
in a strong position to increase
market share as consumers have
the reassurance that the product
is slocked in an ethical environ-
Continued on P95 ►
SAVE
with Counterpart!
you have retained all your counterpart modules the
cost to you will be only £20 (+ VAT) per assistant!
To re order all the modules at £15 (+VAT) and register one
assistant at £20 (+VAT) still works out at only £35 (+VAT)
per assistant. For four assistants the price reduces
even further to £23.75 (+VAT) per
J - J J J J
1
JULY
DEADLINE NOW PAST!
i—i r-i person! r- 1
no
The RPSGB deadline of July 1, by which all pharmacies in
England, Scotland and Wales should have registered their counter
assistants for an accredited training course, has now passed!
If you have not already complied with the RPSGB requirements
don't worry...there's still time. BUT YOU MUST HURRY!
Register your staff now
with the Chemist & Druggist Cambridge
Counterpart Pharmacy Assistant Development Programme - the most
cost-effective course available to Chemist & Druggist subscribers!
# Cambridge Counterpart has been accredited by the College of
Pharmacy Practice as satisfying the RPSGB's requirements.
# Counterpart has been generously co-sponsored by Whitehall
Laboratories for the benefit of Chemist & Druggist subscribers.
# Since the course began in July 1995, subscribers will have
received a total of 13 Counterpart modules.
# The training modules are packs designed to be shared by four
assistants, but include separate questionnaires and case studies
for each individual. An associated Pharmacist's Briefing comes
with each module.
# To qualify for accreditation, assistants must not only follow the
course set out in the modules but also answer the questionnaires,
participate in the case studies and have their questionnaires
independently mar ked thr ough C&D's unique telephone marking
system.
Sign up now!
Here's what you do...
1. If your assistants are already following Counterpart
and are registered for telephone marking. ..continue
with the course. Once it is completed, you will receive
the results and documentation for CPP certification for a
payment of £8.81 including VAT.
2. If your assistants are following Counterpart, but are
not yet registered for telephone marking... use the
form below to register today!
When your assistants receive their personal identity
numbers (PINs), they should enter their multiple choice
questionnaire responses up to date, then follow the
course to the end. CPP certification will be available as
above for £23.50 including VAT.
3. If your assistants are not yet following
Counterpart.. .use the form below now to register them
today. If you have retained the free modules, start your
assistants on the course at once and mark the
questionnaires as soon as PINs are received.
If you do not still have the free modules available, use
the order form to obtain complete packs of the full
course (training modules, questionnaires and
Pharmacist's Briefings) for just £17.63, including VAT.
Remember, each pack will cover four assistants!
PIN registration and CPP certification fees are still
payable as in section 2 above. Subscribers who have
mislaid just one or two modules only should contact
Tracy Matthews on 0181 747 8797
Remember: if your counter assistants have not already completed an approved course or are not
currently following an accredited course, they may no longer serve medicines to the public!
Priority Order Form
YES! My counter assistants are following
Counterpart but are not registered to use the
interactive telephone marking system. Please
register them now @ £23.50 each including VAT.
Name
Name
Name
Name
Name
Name
Total
@£23.50 = subtotal £
YES! I subscribe to C&D at the pharmacy address
below but need ( ) complete sets of all
Counterpart modules to enable my assistants to
complete the course. (Remember to register each
assistant).
Please send me ( ) complete sets of modules
1 -1 3 at the special price of just £1 7.63 inc VAT
If you do not already subscribe to C&D, or your
subscription has lapsed, your cheque must include
an additional £115 for the full annual subscription.
Sub total £
Total payable £
Method of payment: □ I enclose a cheque
payable to Chemist & Druggist
Pharmacy
Pharmacist
Address
Post code
Tel
Fax
Post now in an envelope (no stamp required) with
payment to Sue Cheeseman, Pharmacy Group Special
Projects, Miller Freeman Professional Ltd, Chemist &
Druggist, FREEP0ST, Sovereign Way, Tonbridge, TN9 1YZ.
94
CHEMIST & DRUGGIST 20 JULY 1996
EYE CARE
In the public eye
Customers looking for eye care products usually visit the pharmacy first.
Research shows that as 86 per cent of products are sold here, good
merchandising is essential as customers are more aware of their needs
l-Doc: supported by consumer advertising this summer
< Continued from P93
ment and can seek assistance
from the staff it necessary,"
says Eyecare Products, whose
25 per cent market share
includes the Readi Read, Foster
Grant and Magnivision brands.
I lisplay is the key factor in good
sell-through.
What to choose
• Eyecare Products' 29 styles
conform to British Standards
(European standards pending)
and carry a 12-month guarantee.
All lenses are aspheric, so they
aie thinnei and flatlet than con-
ventional spherical lenses. A
range of Sun-readers pr< ivides 1 A'
protection.
The company's service in-
cludes next day delivery on
repeat orders, low minimum
repeal orders (three pans
mixed), opening deals, free dis-
play stands to suit all si/.es of
outlet, and a lelesales service or
regular merchandising for largei
outlets All displays include an
ophthalmically-appn >ved sight-
tesl inn chart f< ir selecting I he <•< >r-
recl strength.
Future plans for this year
include public relations, further
stand developments, promotional
oilers to the retailei and con
sumer, and a constanl updating of
styles.
• Direct Perception's prices
range from £2.98 to £10.98, w hich
Mr Philips believes should cover
the needs of everyone, from the
person who wants a basic pan to
the one who w ishes to enhance
his appearance with a better
design. Stockists can experiment
with new mi idels, which I he c< >m-
pany is quite happy to exchange if
necessary.
"This way, a stockist of a bud-
get range may gradually test the
market out with better models,"
says Mr Philips. Several promo-
tions will i mi over the next few
mi ml lis.
Modern lifestyles are good for
the eye care market. Pollution,
air conditioning and staring at
computer screens all put strain
on i he eyes.
Research by < )rookes Health-
care shows that the number of
people suffering from minor eye
complaints is on the increase,
with the result that the < »T< ' eye
care market is growing steadily
and is now worth .S 18 million.
About ten million people - over
one-fifth of adults - use < iptrex
and the brand accounts for 71
per cent of the market.
The introduction of < Iptrex
Dry Eye Therapy eye drops in
April was an attempt to expand
the market as a whole and to
offer an < iptrex product in an
area with no other promoted
brands A survey in 1994 found
i hat ( ivei half i he 3.3 millii in dry
eye sufferers were unaware that
remedies existed. Promotion will
be targeted both at these people
and current users of dry eye
I real inents.
This year sees the highest-ever
promotional spend on the< >ptrex
brand Explains product man-
ager Pisa Miller: "By educating
the consumer and increasing
awareness of eye care through
both educat ional i >ublic relatii ms
and high-profile advertising, we
are Stimulating demand for eye
care products and making the
category more accessible to the
ci msumer "
Research shows that 86 per
cent of eye care products are
bought m pharmacies, so
Crookes Healthcare believes that
g I merchandising is essential
as customers become more
aware of their eye care needs and
the role of ' >T< ' medicatii m
ii h i eases in general.
New display units and shell'
managers form pari of this year's
&3m support programme. A two-
tiei countei unit provides space
for 12 packs of the dry eye drops,
as well as a new customei infor-
mation leaflet A flexible modu-
lar shelf management system for
use behind the counter can
house all ( iptrex products,
including Hayfever Allergy. A
new shell manager for use in the
< 1S1> atea houses the lotion and
eye masks,
Rhone-Poulenc Rorer com-
ments that over the past year
Brolene's share has lumped to 22
per cent of the ,S7 (ini eye c are
market through pharmacy
(excluding Boots) and accounts
for 90 per cent of the anti-infec-
I ive segment
OTC marketing manager
kevan (iill explains: "Consumers
are very reluctant to self-diag-
nose where eye problems are
concerned, and need the reassui
ance and recommendation of
then local community pharma-
cist who can offer them a per-
s< dial service."
The c< impany has produced an
eye care counselling pack for
pharmacists and their assistants.
It contains leaflets OI1 the lour
most common complaints
allergic seasonal conjunctivitis,
infective conjunctivitis, blephar-
itis and styes - to pass on to cus-
tomers, after consultation.
An illustrated poster for use
in the pharmacy helps identify
eye problems and gives guidance
on their treatment. Both are
available tree from the com-
pany's representatives.
• Golden Eye drops and oint-
ment are being advertised
nationally on radio, and
Typharm is sponsoring pollen
count bulletins. Advertising is
appealing in the Daily Mail
health pages and women's maga-
zines, as well as some medical
journals. A new range of POS
materials and leaflets is avail-
able from the company. There
are special offers from whole-
salers throughout the summer
and a compel if ion for pharmacy
staff, with prizes of the '( iolden-
eye' James Bond video, runs
until the end i if August.
• A public relations campaign is
in progress for new l-Doc preser-
vative-free eye lotion. There are
advertorials in the women's
press and sampling through the
national Sunday supplements
ami women's interest piess.
Advertising is appearing in the
.luly and August issues of
Options, Mm ir < 'laire and Zcsl.
Containing distilled witch hazel,
l-Doc is packaged in single dose
ampoules w hich contain enough
lotion lo bathe both eyes.
rHKMIST*l)RI(;(ilST?n.ll)LY19R6
BUSINESS NEWS
o RPM - no pharmacy'
On another positive note, 65
per cent intend to expand their
businesses by adopting new ser-
vices, such as consultancies 'in
situ'.
The increasing power of gen-
eral practitioner fundholders
brought mixed reactions. While
Ninety-one per cent of pharma-
cists believe their businesses
would be threatened by the
removal of Resale Price Mainte-
nance, according to a Glaxo Well-
come survey. Eighty-eight per
cent also feel threatened by
changes in Government remu-
neration I lispensing
doctors, meanwhile,
are regarded as pot-
entially harmful by
81 per cent of the
pharmacists. Slightly
lower down the
scale of threats are
wholesaler-owned
outlets, which alarm
75 per cent .
However, most of
the pharmacists are
keen to fight on. Sixty
per cent say they are Ian Millar, a community pharmacist at Seres
not seriously consid- Road Pharmacy in Glasgow, won a Toshiba
ering getting out of Pentium-powered laptop for taking part in Glaxo
retail pharmacy, 24 Wellcome's questionnaire. He is flanked, from
per cent appear to lie the left, by Doug McLean, account manager at
giving the notion Glaxo; Rose-Marie Parr, director of the Scottish
some thought, and 14 Centre For Pharmacy Postgraduate Education;
per cent are seriously and Maureen Devlin, Glaxo's customer manager
considering quitting, (pharmacy)
48 per cent of the pharmacists
say the trend is a threat, 22 per
cent see it as an opportunity.
Forty per cent believe patient
pack dispensing is an opportu-
nity for their business, as
opposed to 20 per cent who see it
as a threat.
The development of primary
care teams is considered good by
60 per cent of the pharmacists,
while 48 per cent see the nurse
prescribing pilot as an opportu-
nity for their businesses.
Glaxo sent out more than 8,000
questionnaires to community
pharmacists around the UK in
April. The company says it will
use the information as a base to
build a better relationship with
them.
The questions ranged from the
respondent's purchasing respon-
sibility to general attitudes
towards key issues. Glaxo says
the response was excellent.
Those who completed the ques-
tionnaire were eligible to win a
laptop computer, software and
modem worth £3,000. Ian Millar,
of Glasgow was the winner.
Co-op Health Care
acquires more stores
Co-op Health Care, the pharmacy
chain operated by United Nor-
west Co-op, has acquired five
pharmacies in the North Mid-
lands and north west of England.
The chain, which now has 49
stores, plans to acquire at least
another six by the end of the year
and will again be looking in these
two regions.
A spokesman for Co-op Health
Care says the latest acquisitions
are in line with its plans to
expand in the North West. More
stores also improve the chain's
buying power, he adds.
The c hain has
been strengthen-
ing its manage-
ment team over
the past year to
cope with its
expansion. New-
comers include
a professional
d e v e 1 o p m e n t
manager to help with recruit-
ment and to maintain profes-
sional standards, and an integra-
tion manager, whose brief is to
aid new branches in assimilating
into the organisation.
Geoff Flint, right, controller of Co-
op Health Care, and Philip
Broadhurst seal the Co-op's
acquisition of Mr Broadhurst's
pharmacy, Stoke-on-Trent-based
JHMcEllin
Astra fights Losec copies
Astra, the Swedish
pharmaceuticals group, has
lodged a complaint with the
European Commission against
Portugal for approving 13 pirate'
copies of its anti-ulcer agent,
Losec, according to the Financial
Times. Astra estimates that it is
losing S12 million annually to
Losec imitations.
Proteus reduces losses
Revenues earned from licensing
agreements and a cost-cutting
programme helped Proteus
International, the Macclesfield-
based biotechnology company, to
reduce its pre-tax losses by £2.5
million to £5.4m for the year to
March 31.
Alberto-Culver expands
Hair care and toiletries
manufacturer Alberto-Culver is
investing £3.15 million in a new
50,000ft 2 manufacturing site at its
base on the Swansea Enterprise
Park in South Wales. The
expansion will create 100 new
jobs.
Sun worshippers
Balmy weather in June brought
very good sales of sun
preparations in pharmacies and
department stores, while demand
fell for cough and cold products,
according to the British Retail
Consortium. The weather also
lifted sales of hay fever remedies.
Demand was mixed for
cosmetics.
Therapeutic flotation
Therapeutic Antibodies, which
produces polyclonal antibodies
to treat diseases, has fallen prey
to the rapid decline of
biotechnology shares. The
company expects a placing price
of 525p per share, valuing it at
£112 million, when it is floated on
the Stock Exchange next week.
The company had originally been
hoping to price its shares at 700-
800p.
Chiro founder reaps reward
Bearish market bites into Alizyme flotation
Chris Evans, founder of Chiro-
science, the biotechnology com-
pany, has turned 816,000 share
options into shares.
Mr Evans, now a non-executive
director of the company, bought
600,000 shares at 25p and 216,000
at 16.67p. Having paid £186,007
for them all, Mr Evans would
make a profit of more than S2.6
million if he sold them at their
market price of 346p [share price
quoted on July 12). However, he is
said lo have no immediate plans
to sell.
Alizyme, a biopharmaceutical
company based in Cambridge,
expec ts a relatively poor recep-
tion when it is floated this week
because of the current bear mar-
ket for biotechnology shares.
It expects to raise about £4.5
million net when it joins the
Alternative Investment Market.
By contrast, three weeks ago,
Alizyme said it was expecting to
raise between £12- 13m through
the flotation.
This week's placing price will
be 60p, valuing the company at
about £10.4m, although it had
originally been hoped to place
shares at 150p.
Alizyme will issue 8.33 million
shares that represent 48 per cent
of the enlarged shar e capital.
It will use the money raised to
fund product development The
company is developing drugs to
combat obesity and gastro-
intestinal disorders. Such drugs
are developed from a late stage
of their research and supervised
through pre-c linical testing to the
end of Phase II trials. The prod-
ucts are then licensed out to
other companies for late stage
trials, commercial manufacturer
and marketing.
The company is collaborating
with Oxford Molecular and the
Institute of Food Research to
develop lipase inhibitors for use
in obesity and atherosclerosis,
and with BTG on drugs for
inflammatory bowel disease,
diarrhoea and flatulence.
38
HHRMIST & DRITfifilST 20 JULY 19
Classified
Appointments £25P.S.C.C. + VAT minimum 3x1
General Classified 123 P.S.C.C. + VAT minimum 3x2
Box Numbers £ 1 2.00 extra. Available on request.
Copy date 4pm Tuesday prior to Saturday publication.
Cancellation deadline 1 0am Friday; one week prior to insertion date
All cancellations must be in writing
Contact Lucy Reynolds Chemist and Druggist (Classified)
Miller Freeman PLC, Sovereign Way, Tonbridge, Kent TN9 IRW
Tel: 01732 377222 Internet: http://www.dotpharmacy.com/
ALL MAJOR CREDIT CARDS ACCEPTED
VISA
Nr Cross Keys, Gwent
EnchusiasiK Pharmacist required to manage
pleasant village pharmacy \ xccllcnt
supporting stafi Pleasant disposition and a
liking tor pjucm contact essential- Hours
and salary negotiable
rdephone Alan Peterson on
01495 244227 (daytime) or
0149S 244226 (evenings).
Full & Part-time
Pharmacist/
Managers
Required
Bournemouth Area
Competitive salary,
holidays & excellent
team of staff,
/t/'/'/t/ Mrs Cough
Tel: 01202 749397
01202 523481
Multi Pharmacy chain require
evening locnms to work in t ho
following stores.
Rygate Surrey 01737 244132
(4pm-10pm)
Hadleigh, Essex 01702 555321
Felixstow, Suffolk 01394 276297
(until Xpm)
Upper Norwood, S. London
01X1 7717639
(until Hpm)
DISPENSING TECHNICIAN
NORTH LONDON
(ISLINGTON N1)
Dispensing/Medical Counter
Assistant required lull time (part
time considered). Newly extended
and refitted pharmacy.
References required
Please phone The Manager
0171-226 3645
APPOINTMENTS
Superintendent Pharmacist
required immediately for high
street pharmacy.
Please contact Mr O. Dede
on 0181 692 5807 9am-7pm
or Miss McCarthy on
0181 692 3725 9am-7pm
DISPENSING ASSISTANT
Burghfield Common, nr. Reading
Experienced dispensing assistant
required part time for a busy
community pharmacy Good rate of
pay.
Phone Mrs Thomas on 01734
831145 (daytime)
or 01734 845740 (eves & w/ends)
SUNDERLAND
Pharmacist manager required for
easily run branch of small friendly
group. No paperwork. Very few
Saturdays.
Apply to P. Henderson, 95 Park
View, Whitley Bay, TVne and
Wear NK26 3RJ or telephone
0191 252 0253
LEWISHAM SEI3
Enthusiastic Pharmacist
Manager required fur an easily
run pharmacy Recently
qualified considered
Please contact: H.C. Patel
0171 476 0243 (daytimel
0181 464 4812 (evening)
LOCUMS
LONDON N7
LOCUM REQUIRED
from 5th August for 6
weeks.
Contact Kirit on
0171 249 2441 (day)
0181 881 3977 (eve)
LIVERPOOL
Manager required for easily run
branch pharmacy, good supporting
staff, attractive salary with profit
sharing incentive. Newly
registered considered.
Apply P. Lappin 0151 236 0618,
0151 722 3926 (eve).
Friendly family pharmacy
group require a
PHARMACIST/MANAGER
for village pharmacy near
Eastbourne. Interested 9
Phone Paul Houston
01323 411047 or 647420
(eves)
LOCUMS
RROVINCIA
LOCUM
We have over 5,000 pharmacists
registered PLUS experience of
handling over 250,000 booking
NATIONWIDE!
' Provided by experienced staff.
1 Locum bone-fides checked.
' A mobile & motivated locum
• Pharmacist staff to deal with
technical issues.
LEAVE THE WORRY TO
PHARMACY
SERVICES
Plena eM
Bvmitqlum 0121-233 0233
NwcaitU 0191-2330506
MmdutU 0161-766 4013
SUffull 0114-2699 937
Edbthwyk 0131-229 0900
Cardiff 01222 549174
London 01892 515963
Exit&t 01392422244
London SW4
Regular lotum pharmacist required
to cover late night dispensing
in Clapham, for Thursdays & Fridays
b-9pm. knowing Mediphase is
desirable. Salary by negotiation.
Telephone Dr. Gharib
0171 622 3147
SELF-EMPLOYED
LOCUMS
+ Are you familiar with 'self-
assessment' rules starting from
April 1996?
* Qualified Accountant provides
a full accountancy/tax service
for reasonable rates.
Tel: 0181 908 5006
Seaton, Devon
Locum required on a
regular basis. Also for
another local pharmacy.
Telephone W. Gaine on
(01297) 20414 or (01297)
21739
LOCUMS
Urgently required in
South Waits & Bristoi area
• Competitive rates oi pay
• Olll) DAYS & LONG TERM AVAILABLE
Contact
Capital Support Services
Tel: 01222 540940
Fax: 01222 54'M«5
CHEMIST ADRI'MilST 20 JULY 1996
57
BUSINESS OPPORTUNITIES
COMPUTER SYSTEMS
BUCKINGHAM
Run your own business without any capital investment.
Unique opportunity has arisen for a Pharmacist with
business acumen to operate this branch on a profit share
basis.
For further details contact H. Modi, Jardines (UK) Ltd.
Telephone 01908 506828.
BUSINESSES FOR DISPOSAL
ALLIANCE VALUERS &
STOCKTAKERS
(01423) 508172
S W WALES COLCHESTER
Retirement sale of unopposed pharmacy in
delightful coastal village. T/O FYE April 95
£426,807. CP 27.4%. NHS items average
3,460 per month Immaculately presented
premises available on new lease or freehold
with attractive four bed living accom if
required Offers invited around £225,000 for
GW/Fix plusSAV.
Long established suburban pharmacy. T/O
FYE April 95 £642,656. NHS items average
5,500 per month. Prominent corner premises
available on new lease at £5,000pa. An
extremely profitable concern. Offers invited
around £400,000 for GW/Fix plus SAV
(approx £55.000)
lOOKING IX) BUY OR SHI A PHAKMAC Y> ( ON I AC I US NOW.
COMPUTER SYSTEMS
% UNTIL THE END OF SEPTEMBER
YOU CAN BUY
'Simply the besf
LABELLING & EPoS SYSTEMS
PHONE TODAY FOR MORE DETAILS
PARK SYSTEMS LTD.
6 Vulcan St, Liverpool L3 7BG
Fax: 0151-298 1689
'Subject to Park's standard terms and conditions
BUSIN
A FREE Service for Chemist & Druggist Subscribers
35, Dansac unique 2-55 ref 502-55.
Trade less 20%+ VAT+ Postage -
Paroven caps 250mg, Loron 520
tabs, Cardura tabs 4mg. Tel: 01923
825753.
TRADE LESS 25%+VAT+POSTAGE -
6 Pergonal 7587 inj+solvent (exp
10/97), 10 DepLxol inj 40mg/2ml (exp
2/98), 4 Fortral 30mg/ml inj (exp
1 1/97), 1x5 5ml Suprefact S/C inj (exp
11/97), 3 Deca-Durabolin 50mg/ml
(exp 3/97), 2 Sustanon 250 1ml inj
(exp 12/97) and many others. Tel:
0181422 2563.
TRADE LESS 20% + VAT +
POSTAGE- Opsite 10cmxl2cm
4630. Trade less 1 5%+ VAT+ Postage
- Coloplast Assura 2471, Comfeel
iOcmxlOcm 3213, Mepore 9x10cm.
Tel: 0171 620 0429.
TRADE LESS 30%+VAT+POSTAGE
- 456 Loron 400mg caps, Farlutal
lOOmg tabs, Provera 400mg Tabs,
Danol 200mg caps, Calcitare vials,
Duocal cans 2x400g, Desferal iiu 1
box. Tel: 0181 672 6116.
TRADE LESS 30%+VAT - 38 Dutonin
200mg, 53 Cedocard Retard 400mg,
90 Hydergine 1.5mg, 3 Lentaron
Depot 250mg, 5 Inj Kemadrin. Tel:
0181 904 4197.
TRADE LESS 30%+VAT - 1 1x30x3118
Hollister, 2x30 Hollister 7164. Tel:
0171-730 1080.
TRADE LESS 25%+VAT - 2x30 Neoral
50mg (exp 7/97), 4x30 Neoral +vat
(exp 9/97), trade less 40% - Norplant
(exp 9/96). Tel: 01793 495499.
TRADE LESS 20%+ VAT - 33 Celectol
200mg, 28 Climesse 2mg, 100 Flur-
biprofen 50mg, 84 Ketoprofen LOOmg,
42 Foradil 12mcg, 28 Monocor lOmg,
80 Volmax 4mg, plus others. Tel:
01827 262488.
TRADE LESS 40% - Suprefact spray,
Cyproterone 50mg £20/56 tablets. Tel:
Increase Profitability
Enhance Customer Care
Increase Staff Motivation j> - ,
Improve Communication m rVOjCSSlOtlM
improve Efficiency I .j Dispensing Systems for
Provide Profes^nTpractfce Image II Professional PhatWadStS
Increase Flexibility II FOR DETAILS
AND/OR A FREE DEMONSTRATION:
Tel: 0161 9417011
PACE BETA COMPUTERS, FREEPOST ALM 1610, ALTRINCHAM, WA14 1AR
IBM computers are amongst the most highly
respected in the industry . They have unequalled
reliabilty, are manufactured in the UK and have a
reputation second to none. It is only fitting they
should run software of equal standing. That
software is JRC.
IBM & JRC, forward thinking , here for
the future.
Call John Richardson Computers
(a division of Taylor Nelson AGB pic)
ON FREEPHONE: 0500 947116
*91% of Community
Pharmacists have read four
out of the last four issues
of Chemist & Druggist.
('source Martin Hamblin Pharmacist Readership Survey)
01582 21760.
TRADE LESS 30%+VAT - Celance
0.25mg x 0.05mg, Dalacin 150nig,
Axid 300nig, Sandimmun 25mg, Lam-
ictal 50mg, Zydol SR, Cipramil 20mg,
Becodisk 150, Berstec 200, Aerobec
Forte. Tel: 01623 643801.
TRADE LESS 30%+VAT - 300 Lopid
300mg (exp 10/96), 100ml Bactrim
Paed syrup (exp 9/96), 2x56 DMC
90mg (exp 8/96), trade less 40%+vat,
100 Kinidin duniles (exp 9/96). Tel:
01438 312228.
TRADE LESS 20% + VAT +
POSTAGE - 6x30 Convatec Com-
bihesive pouches 45mm S265, 4x10
Stomahesive flange 45mm S241
Tel: 01792 458883.
TRADE LESS 30%+VAT - 15 Vagifem
(exp 2/97), 56 Lederfen 450 (exp
8/99), 50 Lodine 200mg ( exp 6/97), 56
Ludiomil 25mg, 100 Tegretol retard
400mg (exp 6/97), 3x28 Climagest
(exp 1 1/96), 3x28 Climagest lgm (exp
6/97), 30 Voltaren lOOmg (exp 3/97).
Tel: 01 16-283 2140.
TRADE LESS 30%+VAT - 1x250 Hex-
opal forte dispensing pack (exp 7/00).
Tel: 01667 462617.
TRADE LESS 25%+VAT - 10x28 Nys-
tan pessaries (exp 1/97), 10x150
Atarax syrup (exp 5/00), 36x42 Para-
max tabs (exp 11/98), 6x30 ManerLx
(.exp 9/99). Tel: 01274 593274.
TRADE LESS 60% + VAT - 7 Oxygen
stands, unused, 5.5 inch, new price
S16.16+vat. Tel: 0181-684 1352.
FOR SALE
QUALITY SHOPFITTINGS Less
than three years old, four perfume
cabinets, two counters, gondola,
shelves, dispensary fittings, conti-
nental drawers, light fittings, safe
and Mediphase computer. Tel:
01494 520685.
MARTINDALE 29TH EDITION As
new, hardly used £40. Tel: 0181-684
1352.
PARK SYSTEM SOFTWARE Version
7, Packard Bell 486 Multimedia 8MB
RAM, Star colour printer, complete
system, ready to run £800. Tel: 01474
352609.
MINI LAB Oriental mini 2, complete
system which prints up to 8x12, 100
films a day, ideal for busy phar-
macy, one year old Tel: 01703
869820.
CHEMIST & DRUGGIST 20 JULY 1996
COMPUTER SYSTEMS
PRODUCTS AND SERVICES
+ CAMRx +
FOCUSING ON THE FUTURE.
PERSONAL AND VALUABLE
SERVICE AT ALL TIMES
Alchemist 3000 PMR
dispensary system
NEW VERSION !!!!!!
Prophet 2000 EPOS
Intelligent till system
Transform your business
All
Net-Workable
We use our
engineers
We deliver &
install FREE
Police Station
'i>l ffl I 77 7\ f,7
DISTRIBUTORS WANTED
CLEARWAY INHALER is now established as the
preferred way of inhaling steam and aromatics in the
treatment of catarrh, sinusitis, coughs and colds.
We now require distributors willing and able to
promote and sell to community pharmacies. Please
reply to Clearway Products Ltd., Kiln House,
Station Road, Wisbech St. Mary, Cambs. PE13
4RW or telephone 01945 410466 for further
information.
JOIN THE GROWING BAND
of PEOPLE who INCREASE
their PROFITS by £££££'s
1. A vital invc
base will p
ridable negotiati
2. Group 31 o ^jMj) adds pounds to
3. Our negotiating skills, contacts and know
how will bring you extra savings from
numerous companies.
COULD REVOLUTIONISE YOUR BUSINESS
54/62 Silver Street, Whitwick, Leicestershire LE67 3ET
TEL: 01530 510520 FAX: 01530 811590
RING FOR DETAILS ON
FREEPHONE 0800 526074
COPY DEADLINE FOR THE
27TH JULY IS TUESDAY
23/07/96 - CALL 01732 377 222
BUSINESSlink
A FREE Service for Chemist & Druggist Subscribers
EXCESS STOCK
S25.00 + VAT + POSTAGE - 10 x
Cusilyn eye drops 13.5m] (soil cro-
moglycate 2%) exp 1/97. Tel: 01223
568190.
TRADE LESS 50% + VAT +
POSTAGE - Coloplast - 1285 4x10,
12705x50, 1200 2x30, 12507x5, Sur-
gicare SI 00 2x5, S351 1x5, S240
1x10, SI 1x4, Conveen S125 2x30,
S120 1x10, S172 1x10, S236 1x10,
S272 2x10, S313 1x10, Dansac 226-
60 4x30, 226-40 1x30, 226-45 2x30.
Tel: 01202 262486.
TRADE LESS 50%+VAT - 63 Dol-
matil 200mg (exp 10/96), 66 Neu-
rontin lOOmg (exp 8/97). Tel: 01269
822217.
TRADE LESS 30%+VAT - 2x42 Val-
trex tabs (exp 10/96), 3 boxes Corn-
fell over dressing 20cm 2 Tel: 0171
485 1251.
TRADE+VAT - 190 Pentasa M/R 500mg
(long expiry) Tel: 0121 477 0123.
TRADE LESS 25%+VAT+POSTAGE -
260 Megace tabs 40mg (exp 11/98),
5x100 Hormonin tabs (exp 2/08),
1x120 Alu-cap caps (exp 3/07) Tel:
0181 651 6062
TRADE LESS 50%+VAT - 4 boxes
Predfoam enemas (exp 8/96 & 12/06),
3x5Cytamen inj 1000mg(exp 11/96),
3 Zofran inj 2mg/ml (exp 0/07), 60
Loron 520 tabs (exp 1/98), 12x4ml
Uromitexan inj (exp 11/98), 1 I)e-Nol
labs (exp 11/98), 100 Parlodel lmg
(exp 1 1/96) plus others. Tel: 0161 480
6422
TRADE LESS 50%+VAT - 10 vials
Genotropin 16iu, Kabivial multidose
(exp 10/96) guaranteed fridge stored,
buyer to arrange colleciioti Tel
01382 611227.
TRADE LESS 25% + VAT - Duphalac
dry sachet, Alrheunial caps,
Alphoditl) (team, Kersanial labs,
1000 Triludan OTC packs. Trade less
20%+ VAT - Zofran 8mg. Tel: 0181 520
5820.
TRADE LESS 50%+VAT - 2x10
Normegon 150iu (exp 10/06) Tel
01227 457830.
TRADE LESS 50%+VAT - Provera
400mg, Nicotinic acid 50nig, Rocal-
tro!0.5mcg, Importal Danazol lOOmg,
Targocid 400mg, Cesamet lmg,
Litarex Minodiab 2.5mg, Loniten
5mg. Tel: 0181 874 1405.
TRADE LESS 30%+VAT+POSTAGE
1 Predfoam, 120 Anturan 200mg, 60
Coracten lOmg, 80 Mexitil 50mg, 408
Mexit.il 200mg,30 Provera 400mg, Tri-
nordiol, .84 Gamanil. Tel: 01963
25025!).
TRADE LESS 25% + VAT+POSTAGE
Cardene SR 45 x 56 (exp 10/96), Cor-
win200mgx 186 (exp 11/97"), Retrovir
250mg x 37 (exp 7/97). Tel: 0191 528
4444.
TRADE LESS 40%+VAT+P&P - 80
Aspav (exp 12/96), 16 Coloplast
a.ssuia uro bags 2550, 25 Voltarol
50mg suppositories (exp 11/96), 32
white Tenoretic (exp 2/97), 4x28
Sinequan 25mg (exp 8/98), 2 packs
Napratec (exp 11/96), 25 Adizem SR
90mg (exp 11/96) and many others
Tel: 01693 8:30261.
TRADE LESS 30%+VAT - 6 Lentaron
t.m depot 250mg (1 ampoule
250mg/l ampoule of 2ml) in each
box. Tel: Blackpool 301522.
TRADE LESS
30%+VAT+POSTAGE - Zinamide
500mg, Dansac unique 2-55 ref 555-
35, Dansac unique light 35 ref 255-
EXCESS STOCK CAUTION
Pharmacists are responsible for the quality, safety and efficacy of
medicines they supply. In purchasing from sources other than
manufacturers or licensed wholesalers, they must satisfy them-
selves about product history, conditions of storage and so on.
CHEMIST & DRUGGIST 20 JULY 1996
PRODUCTS AND SERVICES
medieltte pic
Tel 0181 841 4144 Fax: 0181 841 H i ■%
BRflun
INDEPENDENT 2000 ENERGY CELLS
BUY 50 mm CELLS GET 5 MINI CELLS FREE
MEDIELITE=PROFIT PLUS
The Power
of Multiples . . .
...the Privilege
if Independence
UK's fastest growing
buying network of 800
independent
pharmacist
* join us now *
Wish to become a member? Nucare pic
Please contact us Today. 447 Keruon Road
Harrow
Middlesex HA3 OXY
Tel: 0181-732 2772
Fax: 0181-732 2774
CHEMIST & ^ ers ^ e mos ^ com P re ^ ens ^ ve selection of products
TppTCT& services of in any Pharmaceutical Publication.
VMmm. call Lucy on 01732 377222
To pit your Products & Services in front of our unique readership
Free entries in
"Business Link"
(maximum 30
words) are
restricted to
community
pharmacist
subscribers to
Chemist &
Druggist. No trade
advertisements will
be permitted.
Acceptance is at the
discretion of the
Publishers and
depends upon space
being available.
Send proposed
wording to
"Business Link"
using the form
printed alongside.
To: Business Link, CHEMIST & DRUGGIST, Miller Freeman House,
Sovereign Way, Tonbridge, Kent TN9 1RW.
PLEASE COMPLETE IN BLOCK CAPITALS
Surname . . .
First names .
Address
Postcode
Personal RPSGB Registration number
Telephone Number
Proposed advertisement copy (maximum 30 words)
100
CHEMIST & DRUGGIST 20 JULY 1996
SHOPFITTINGS
SPECIALS
5f|opriTfiNc;
FROM LOW COST PERIMETER SHELVING TO
UPMARKET PERFUMERY SHOWCASES TRADITIONAL
OR CONTINENTAL DISPENSARIES
CONTACT MARTIN BAGG FOR A COMPLETE
SHOPFITTING SERVICE FOR THE PHARMACIST
01392-216606
WOODSTYLF
Y Y SHOPFITTING AND DESIGN ■
SPECIALISTS IN RETAIL PHARMACY
AND DISPENSARY SHOPFITTING
APPROVED BY THE N.PA.
CALL NOW FOR DETAILS
Edison Road, St Ives Industrial Estate, St Ives
Huntingdon, Cambs PE17 4LF
Telephone: 01480 494262 Fax: 01480 495826
SPECIALISING IN THE DESIGN
& SHOPFITTING FOR THE
PHARMACY TRADE.
FOR YOUR INDIVIDUAL NEEDS
TEL: 01392 491920
TEL: 01392 49HH22
the key to
solve your pharmacy
diofijjitiuuf. problems ^^r-^y — ^
• comprehensive service • part or full refits " N^n-*^
• competitive quotations • free advice 'budgets
write/telephone: fredenck moore, 39 cooks meadow
edlesborough, beds Iu6 2rp a 01525 222526
name & address
43?
Manufacturers of Special . Pharmaceutical Products
Bespoked Tailors of Pharmaceuticals offering
A TRADITIONAL SPECIALS SERVICE
for that "specials" patient cared for by that special
professional
Where confidence in quality and price is a must and where the
minimum order value is ONE.
Contact Karol Pazik, Director, on 01296 394142.
Mandeville Medicines, The Specialists in Specials.
For sterile, non-sterile and assembled specials, clinical trials
supplies and a free help line
STOCK FOR SALE
5 x 60 MST lOOmg 50% off trade.
500 x 60 SELEGILINE 5mg 42% off trade.
60 x 28 ZESTRIL 5mg 48% off trade.
130 x 28 ISOSORBIDE MONONITRATE 60SR 35% off trade.
15 x 25 ZOVIRAX 400mg 40% off trade.
1000 x 24 exp own brand films 35mm 80 pence each.
Contact: Kasumba Chemist
261 Chesterfield Road, Sheffield, S. Yorks. S8 0RT
Tel: 0114 255 4361
STOCK WANTED
WANTED
Old chemist shop fittings, drug runs, bow
cabinets etc.
Complete shop interiors purchased. We try
hardest, travel furthest, pay more.
Telephone 01327 349249 days.
01327 341192 Eves. Fax: 01327 349397
CHEMIST - WANTED - PHARMACY
Surplus Coloured Glass Bottles and Jars Wanted.
Black Glass Jars. Drug Jars - Blue or Green.
Blue Castor Oils. Coloured Soda Syphons.
"Admiralty" Square Blue Poisons. Spare Stoppers.
Common Blue "Not to be taken" Poisons - All shapes.
Mixed Assortments of Surplus Bottles as above.
Contact: Eric Padfield,
18 Mulberry Gardens, Sherborne, Dorset.
Tel: 01935 816073 Fax: 01935 814181
HEMEX SHOW PA
LUCY OR DEBBI
377222
To?
CHEMIST & DRUGGIST 19%
101
UTDeoDle
Dental aid delivery to Bihac
A pharmacist has been involved
in a live-day trek across Europe
to deliver essential dental sup-
plies to Bihac in the north west of
Bosnia.
Stephen Beasley, a pharmacy
manager at R A Hopkins in
Luton, Bedfordshire, made the
journey last month to deliver
54,500 of dental supplies as part
of the work of local charity
Balkan Relief. Bihac, with a pop-
ulation of 180,000, has not seen
real dental care for over four
years.
Mr Beasley has been involved
with fund-raising for the charity
and organised a sponsored swim
in April. Septodont UK donated
2,000 local anaesthetic vials and
sterile needles, and gave sub-
stantial discounts on other prod-
ucts. Luton dentist Donald
Cousin helped arrange the dona-
tion of other supplies.
The delivery, which also in-
cluded new drills and materials
to make dentures and fillings,
was made to Bihac hospital. "It
should enable routine dentistry
to be carried out for several
months," says Mr Beasley. "Imag-
ine having your tooth filled with
a blunt drill and no anaesthetic."
Food, clothing, bicycles and
toys were also taken in the truck
that was co-driven by Philip
Waters, a director of the stock-
taking company Take-Stock. The
brewer, Bass, supplied funds to
pay for the truck's fuel.
Stephen Beasley (centre) meets Adem Yusufagic, a dentist at the Bihac
hospital dental clinic, whose relatives are refugees in the Luton area.
Mr Beasley delivered news from them to Mr Yusufagic and his mother
usmess news
There is another new face at
Chemist & Druggist.
The recent restructuring of the
editorial team has seen Guy
L'Aimable (above) appointed as
business editor
Guy, who has ten years of
reporting experience, joins C&D
from World Tobacco where he
was assistant editor for four and a
half years. His previous experi-
ence includes four years spent
with Reed Business Publishing.
Feeling a little bit under the weather?
The two main topics of interest to
the British are their health and the
weather. What was on television
last night also ranks highly as a con-
versation topic.
Now the British public can have
their fill of all three with the launch
of the 24-hour cable television
channel 'The Weather Network'.
Not only will the station pro-
vide updated weather reports
round the clock, it is also going to
feature health tips presented by
pharmacist Sharon Buckle.
Ms Buckle works as group pub-
lic relations manager for Boots the
Chemists, and was approached by
the TV company to provide short,
educational health promotion
inserts for broadcasting.
Stars in his eyes ...
A face that may become more
familiar to you on television is
getting a second airing on this
page.
Ortis Deley recently hosted his
own television programme, but
he appeared on this page in Octo-
ber 1994 when he was still a Sun-
derland pharmacy student.
Back then, he was taking part
in 'Blind Date' on ITV. When he
sang for presenter Cilia Black, his
talent was spotted and he was
signed up by an agent.
His new show, 'Passport to Pas-
sion', was shown two weeks ago
in the Friday night post -pub slot
on ITV. The pilot programme had
Ortis and co-presenter Sarah
Matravers setting out "to discover
whether Copenhagen is really a
place to find tare romance".
"I was over the moon when I
was asked to present 'Passport to
Passion' - and I really enjoyed
doing it," he says.
Although he graduated, Ortis
has yet to qualify as a pharmacist.
It seems the bright lights hold
more attraction and he is now
poised to sign a record deal.
CPP exam success
The College of Pharmacy Prac-
tice has announced that it has
seven new full members.
The candidates who have suc-
cessfully completed the Col-
lege's membership examination
are Alison Archer, Barend
Arrthon, Raymond Atkinson,
Nickos Efthynriou, Elizabeth
Hardman, Alisorr MacRobbie and
Lesley Webster.
The closing date for registra-
tion to the College's Assessments
D, E and F examinations is
August 9. Reports for Assess-
ments D and F should be submit-
ted by August 23.
Further details can be ob-
tained from Michelle Chaplin at
the College by telephoning 01203
692400.
The former president of the Royal Pharmaceutical Society has been
presented with the College of Pharmacy Practice's Schering Award.
The presentation was made at the College's award dinner last month in
Stratford-upon-Avon. Pictured are (standing, from left) Professor
Graham Calder, speaker Clive Jackson, Brian Riley, Norman Morrow,
Schering Health Care managing director Mike Wallace and College
chairman Dr David Anderson; (seated, from left) Mary Tompkins, Ann
Lewis, Joan Greenleaf and Elizabeth Roddick
All rights reserved. No part, of this publication may be reproduced or transmitted in any form or by any means, electronic or mechanical including photocopying, recording or any information storage
or retrieval system without the express prior written consent of the publisher. The contents of Chemist. & Druggist are subject to reproduction in information storage and retrieval systems. Miller
Freeman Professional Ltd may pass suitable reader addresses to other relevant suppliers. If you do not wish to receive sales information from oi lier companies please write to Ben Martin at Miller
Freeman Professional Ltd. Origination by London Scanning, 24a Shore Rd, London. Printed by St Ives (Gillingham) Ltd, Gillingham, Kent. Registered at the Post Office as a Newspaper 22/19/24S
m.
CHEMIST & DRUGGIST 20 JULY 1996
: H E M E X ' 9 6 COLY M PIaT) 1 - 2 SEPTEMBER 19
New look
hemex...
New home...
id a New era
emex '96 is a bigger better
dw. Two floors of Olympia
dedicated to pharmacy
□ducts, to beauty and
althcare, to current topics
d to help you maximise
ur business potential..
10 floors which will
3vide you with:
ie New NPA Village
i arena where existing and
tential members, may see and
ar what their trade association
Joing. A place where you can
ve your say and to seek advice
current issues.
ie New International
ivilion
ijor international companies will
showing you what is new and
lat will be arriving on the domes-
market in the near future.
ie New Demonstration
and
new concept to provide all
itors with an opportunity to see
citing new products and services
action and a chance for you to
.t the best before you buy.
;w Seminars and Workshops
rpose built theatres will be the
itform for a series of provoking
d serious discussions which relate to
jr business, your profits, and how to
nerate new growth without com-
3mise. What to do, how to do it, and
w to monitor the results. Subjects on
s draft programme include;
iecurity
Original Pack Dispensing
Alternative Therapies
)avid and Goliath... how to work in
larmony in the face of competition
rom the multiples
Vill IT work 7 .. Computing and its
ole in the pharmacy
No hard drive
to Chemex. . .
Vhat's new
nake profit
and will what's new
m
but you could win
a 2Gb hard drive at
Chemex this year \
15m b EDO RAM,./-gnt^ peakers and Wind ows 95,
keyboard, sound ca
The New Visitors Voucher Book
An exciting new concept. Every registered
visitor to Chemex '96 will receive a voucher
book bursting with special offers and
promotions. So you know where the best
deals and the best incentives are before
you even enter the exhibition hall.
Stunning New Promotions
Early indications show that a number of
companies are supporting the biggest
and most spectacular prizes ever seen
at Chemex... so if you wish to increase
your chances of winning... register now.
The New Trade Show
Every floor will be bustling with activity
and this year's exhibition bookings
would indicate that the recession is
dead. Hundreds of exhibitors all eager
to keep you abreast of the latest devel-
opments... and gossip! Special offers,
exclusive to Chemex '96, will be the
common theme.
New Venue
Olympia 2 welcomes Chemex '96 to its
new improved facilities. Olympia 2 has
all the advantages you would expect
from an international exhibition
centre, convenient to all mainline
railway stations as well as having its
own tube station. Olympia 2 also
features parking for up to 2100
cars, so you will be assured of
easy and convenient access.
New Registration
Competition - win a
Multimedia Pro 120 PC
When you pre-register you will receive the
opportunity to win, for your business, a state
of the art Pentium 120 Multimedia PC com-
plete with 16mb EDO RAM, 2 Gb hard drive,
Eight speed CD ROM, IS" SVGA colour monitor,
keyboard, sound card with speakers and
Windows "95, to boot 1 Every pre-registered
visitor will be entered inio our tree to enter
draw The winner will be advised of their suc-
cess at Chemex '96 In addition all visitors
who pre-register will receive a compliment-
ary free gift pack of TRU-ALO, with a retail
value of £23 25 Your gift pack will include
Soothing Gel, Moisturiser, Moisturiser with
Vitamin E, Antiseptic Cream and Liniment.
boot.
WORTH OVER £1*00
Sponsored by
CHEMIST&
DRUGGIST
Supported t
MEMEX '96
he UK show for pharmacists/
pharmacy buyers.
141 M;l l- r I : . •: i;
Miller Freeman Exhibitions Ltd.
Marlowe House, 109 Station Road
Sidcup, Kent DA15 7ET
Internet: www.mf-exhibitions.co UK
For the treatment ^
of verrucas, warts, V<**
corns and calluses
■ Uniquely formulated, clinically proven treatment
■ Dries to form a water-resistant, protective barrier
■ Designed to inhibit spread of the verruca/wart infection
■ No plasters necessary ■ Simple, once-daily application
i
A bullseye for Bazuka!
Bazuka Gel has taken the verruca/wart
market by storm, soaring to brand leadership
within months of its launch.
With its clinically proven prescription
heritage Bazuka offers simple, effective
treatment for verrucas, warts, corns and
calluses. It dries to form a unique, water-
resistant protective barrier designed to
help inhibit the spread of the verruca/wart
infection, without the need for plasters.
And wtfith continued heavyweight national
press, radio and TV support, Bazuka sales
will go from strength to strength. Be sure
to keep up with demand!
lor the treatment of verrucas, warts, corns and calluses
171
salicylic acid, lactic acid
FORMS A WATER-RESISTANT BARRIER - NO NEED FOR PLASTERS
BAZUKA Trademark and Product Licence held by Diomed Developments Ltd , Hitchin, SG4 7QR, UK Distributed by DDD Ltd , 94 Rickmansworth Road. Wattord. Herts. WD1 7JJ. UK Active Ingredients:
Salicylic Acid BP 12 0% w/w, Lactic Acid BP 4 0% w/w Also contains Camphor BP, Pyroxylin BP, Ethanol (96%) BP, Ethyl Acetate Indications: For the treatment ot verrucas, warts, corns and calluses
Directions lor adults, including the elderly, and children: Apply one or two drops to the lesion and allow to dry to form a small white patch The following day. carefully peel or pick oft the dried patch,
and apply fiesh gel Once every week, before applying Iresh gel, gently rub the treated surface with the emery board provided Continue treatment until the condition has resolved This may take up to 12
weeks for certain vemicas and warts Contra-indications: Not to be used on the face or anogenital regions, or by diabetics or individuals with poor blood circulation Not to be used on moles, birth marks,
hairy warts, oi any othei lesion loi which the gel is not indicated Not to be used in cases of sensitivity to any ot the ingredients Precautions and Warnings: Keep away from the eyes, mucous membrane
and from cuts and grazes Avoid spreading onto surrounding normal skin Do not use excessively Some mild, transient irritation may be expected, but in cases of more severe irritation, treatment should be
discontinued Avoid inhaling vapour, and keep cap firmly closed when not in use Avoid contact with clothing, fabrics, plastics and other mat erials as it may cause damag e Keep all medicines out of the reach
ill i hildren HIGHLY FLAMMABLE Keep away from flames Store at room temperature (not exceeding 25°C), with the cap replaced tightly jFOR EXTERNAL USE ONLY [ Legal Category: [T] (PL 0173/0161)
Packs: 5g, RSP E4 35 (£3 70 exc VAT) 5/95
